Benjamin M Ellingson

Title(s)Professor, Radiological Sciences
SchoolMedicine
Emailbellingson@mednet.ucla.edu
ORCID ORCID Icon0000-0002-2764-6640 Additional info
vCardDownload vCard
    Other Positions
    Title(s)Professor, Psychiatry and Biobehavioral Sciences

    Title(s)Professor, Neurosurgery


    Collapse Biography 
    Collapse Education and Training
    Milwaukee School of Engineering, Milwaukee, WIBS2003Biomedical Engineering
    Marquette University, Milwaukee, WIMS2005Biomedical Engineering
    Marquette University & Medical College of Wisconsin, Milwaukee, WIPhD2008Functional Imaging - Biomedical Engineering
    Medical College of Wisconsin, Milwaukee, WIFellowship2010Radiology / MRI Physics
    Collapse Awards and Honors
    International Society for Magnetic Resonance in Medicine (ISMRM)2010W.S. Moore Young Investigator Award in Clinical Research
    American College of Radiology Imaging Network (ACRIN)2012ACRIN Young Investigator Award
    Johnny Mercer Foundation2013Art of the Brain - Johnny Mercer Foundation Brain Tumor Research Award
    Society for Neuro-Oncology (SNO)2019SNO Award for Excellence in Neuroimaging

    Collapse Overview 
    Collapse Overview
    Dr. Ellingson is the Director of MRI Research and a Professor of Radiology, Psychiatry, Bioengineering, and Neurosurgery within the David Geffen School of Medicine at the University of California Los Angeles (UCLA). Dr. Ellingson is also the Director of the UCLA Brain Tumor Imaging Laboratory (BTIL) and Co-Director of the UCLA Center for Computer Vision and Imaging Biomarkers (CVIB), where his research focuses on the development, testing, validation, and implementation of advanced MR and PET imaging biomarkers for early diagnosis, biological characterization, and therapeutic response assessment in neuro-oncology.

    Dr. Ellingson has co-authored more than 250 peer-reviewed original research articles and holds several patents relating to neuroimaging. Dr. Ellingson has significant experience in the integration, quantitation, and interpretation of imaging in multicenter clinical trials, is on several academic and patient advisory steering committees, and holds many advisory roles with industry partners relating to advanced imaging techniques, radiographic response assessment, and image interpretation in brain tumor clinical trials.

    Collapse Research 
    Collapse Research Activities and Funding
    Targeting the EGFR Signaling Network in Glioblastoma
    DoD CDMRP CA220732Sep 1, 2023 - Aug 31, 2028
    Role: Principal Investigator
    Quantitative molecular MR-PET imaging of glycolysis in glioblastoma
    NIH/NCI R01CA279984Feb 10, 2023 - Feb 9, 2028
    Role: Principal Investigator
    Role of decorin and diffusion MRI in anti-VEGF efficacy for recurrent glioblastoma
    NIH/NCI R01CA270027Apr 1, 2022 - Mar 31, 2027
    Role: Principal Investigator
    Simultaneous multinuclear (Na+/H+) metabolic MRI for sodium-, pH-, and oxygen-sensitive images in human brain tumors
    DoD CDMRP CA200290Aug 1, 2021 - Jul 31, 2024
    Role: Principal Investigator
    Metabolic MRI for quantifying aerobic glycolysis and immune function in gliomas
    NIH R21CA223757Jan 11, 2018 - Dec 31, 2019
    Role: Principal Investigator
    UCLA Brain Tumor SPORE: Core 2: Neuro-Imaging Core (NIC)
    NIH/NCI P50CA211015Aug 11, 2017 - Jul 31, 2027
    Role: Core Principal Investigator
    Spinal and Cerebral biomarkers for measuring disease progression and prognosis in chronic spinal cord injury
    NIH R01NS078494Sep 26, 2012 - Feb 28, 2023
    Role: Co-Principal Investigator
    Cell invasion, motility, and proliferation level estimate maps in gliomas
    NIH R21CA167354Sep 17, 2012 - Aug 31, 2015
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Radio-pathomic estimates of cellular growth kinetics predict survival in recurrent glioblastoma. CNS Oncol. 2024 Dec 31; 13(1):2415285. Oshima S, Yao J, Bobholz S, Nagaraj R, Raymond C, Teraishi A, Guenther AM, Kim A, Sanvito F, Cho NS, C Eldred BS, Connelly JM, Nghiemphu PL, Lai A, Salamon N, Cloughesy TF, LaViolette PS, Ellingson BM. PMID: 39535237; PMCID: PMC11562955.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Efficacy of Adding Veliparib to Temozolomide for Patients With MGMT-Methylated Glioblastoma: A Randomized Clinical Trial. JAMA Oncol. 2024 Oct 31. Sarkaria JN, Ballman KV, Kizilbash SH, Sulman EP, Giannini C, Friday BB, Butowski NA, Mohile NA, Piccioni DE, Battiste JD, Drappatz J, Campian JL, Mashru S, Jaeckle KA, O'Brien BJ, Dixon JG, Kabat BF, Laack NL, Hu LS, Kaufmann T, Kumthekar P, Ellingson BM, Anderson SK, Galanis E. PMID: 39480453; PMCID: PMC11528341.
      View in: PubMed   Mentions: 1     Fields:    
    3. Diffusion MRI is superior to quantitative T2-FLAIR mismatch in predicting molecular subtypes of human non-enhancing gliomas. Neuroradiology. 2024 Oct 08. Cho NS, Sanvito F, Le VL, Oshima S, Teraishi A, Yao J, Telesca D, Raymond C, Pope WB, Nghiemphu PL, Lai A, Salamon N, Cloughesy TF, Ellingson BM. PMID: 39377927.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors? Neuro Oncol. 2024 Oct 03; 26(10):1805-1822. van den Bent MJ, French PJ, Brat D, Tonn JC, Touat M, Ellingson BM, Young RJ, Pallud J, von Deimling A, Sahm F, Figarella Branger D, Huang RY, Weller M, Mellinghoff IK, Cloughsey TF, Huse JT, Aldape K, Reifenberger G, Youssef G, Karschnia P, Noushmehr H, Peters KB, Ducray F, Preusser M, Wen PY. PMID: 38912846; PMCID: PMC11449017.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Pseudo-Resting-State Functional MRI Derived from Dynamic Susceptibility Contrast Perfusion MRI Can Predict Cognitive Impairment in Glioma. AJNR Am J Neuroradiol. 2024 Oct 03; 45(10):1552-1561. Cho NS, Wang C, Van Dyk K, Sanvito F, Oshima S, Yao J, Lai A, Salamon N, Cloughesy TF, Nghiemphu PL, Ellingson BM. PMID: 38719607; PMCID: PMC11448991.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Digital "flipbooks" for enhanced visual assessment of simple and complex brain tumors. Neuro Oncol. 2024 Oct 03; 26(10):1823-1836. Cho NS, Le VL, Sanvito F, Oshima S, Harper J, Chun S, Raymond C, Lai A, Nghiemphu PL, Yao J, Everson R, Salamon N, Cloughesy TF, Ellingson BM. PMID: 38808755; PMCID: PMC11449060.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Targeted radionuclide therapy for patients with CNS metastasis: overlooked potential? Neuro Oncol. 2024 Oct 01. Le Rhun E, Albert NL, Hüllner M, Franceschi E, Galldiks N, Karschnia P, Minniti G, Weiss T, Preusser M, Ellingson BM, Weller M. PMID: 39351771.
      View in: PubMed   Mentions:    Fields:    
    8. "Synthetic" DSC perfusion MRI with adjustable acquisition parameters in brain tumors using dynamic spin-and-gradient-echo echoplanar imaging. AJNR Am J Neuroradiol. 2024 Sep 12. Sanvito F, Yao J, Cho NS, Raymond C, Telesca D, Pope WB, Everson RG, Salamon N, Boxerman JL, Cloughesy TF, Ellingson BM. PMID: 39242197.
      View in: PubMed   Mentions: 1     Fields:    
    9. A Neuroradiologist's Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults. AJNR Am J Neuroradiol. 2024 Sep 05. Ellingson BM, Sanvito F, Cloughesy TF, Huang RY, Villanueva-Meyer JE, Pope WB, Barboriak DP, Shankar LK, Smits M, Kaufmann TJ, Boxerman JL, Weller M, Galanis E, Groot J, Gilbert MR, Lassman AB, Shiroishi MS, Nabavizadeh A, Mehta M, Stupp R, Wick W, Reardon DA, Vogelbaum MA, van den Bent M, Chang SM, Wen PY. PMID: 38926092.
      View in: PubMed   Mentions: 1     Fields:    
    10. IBS stress reactivity phenotype is associated with blood transcriptome profiles and microstructural and functional brain changes. medRxiv. 2024 Aug 08. Labus JS, Delgadillo DR, Cole S, Wang C, Naliboff B, Chang L, Ellingson BM, Mayer EA. PMID: 39211876; PMCID: PMC11361226.
      View in: PubMed   Mentions:
    11. RANO 2.0 criteria: concepts applicable to the neuroradiologist's clinical practice. Curr Opin Oncol. 2024 Nov 01; 36(6):536-544. Sanvito F, Castellano A, Cloughesy TF, Wen PY, Ellingson BM. PMID: 39011735; PMCID: PMC11493521.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    12. Effect of Jardiance on glucose uptake into astrocytomas. J Neurooncol. 2024 Sep; 169(2):437-444. Ghezzi C, Ellingson BM, Lai A, Liu J, Barrio JR, Wright EM. PMID: 39037688; PMCID: PMC11341586.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Sex-specific alterations in functional connectivity and network topology in patients with degenerative cervical myelopathy. Sci Rep. 2024 07 11; 14(1):16020. Oughourlian TC, Rizvi S, Wang C, Kostiuk A, Salamon N, Holly LT, Ellingson BM. PMID: 38992236; PMCID: PMC11239916.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Author Correction: TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial. Nat Commun. 2024 Jun 05; 15(1):4800. Everson RG, Hugo W, Sun L, Antonios J, Lee A, Ding L, Bu M, Khattab S, Chavez C, Billingslea-Yoon E, Salazar A, Ellingson BM, Cloughesy TF, Liau LM, Prins RM. PMID: 38839763; PMCID: PMC11153605.
      View in: PubMed   Mentions:    Fields:    
    15. Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma. Clin Cancer Res. 2024 May 15; 30(10):2048-2056. Schreck KC, Strowd RE, Nabors LB, Ellingson BM, Chang M, Tan SK, Abdullaev Z, Turakulov R, Aldape K, Danda N, Desideri S, Fisher J, Iacoboni M, Surakus T, Rudek MA, Bettegowda C, Grossman SA, Ye X. PMID: 38446982; PMCID: PMC11096001.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    16. TLR agonists polarize interferon responses in conjunction with dendritic cell vaccination in malignant glioma: a randomized phase II Trial. Nat Commun. 2024 May 08; 15(1):3882. Everson RG, Hugo W, Sun L, Antonios J, Lee A, Ding L, Bu M, Khattab S, Chavez C, Billingslea-Yoon E, Salazar A, Ellingson BM, Cloughesy TF, Liau LM, Prins RM. PMID: 38719809; PMCID: PMC11078958.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    17. Noninvasive Autopsy-Validated Tumor Probability Maps Identify Glioma Invasion Beyond Contrast Enhancement. Neurosurgery. 2024 Sep 01; 95(3):537-547. Bobholz SA, Lowman AK, Connelly JM, Duenweg SR, Winiarz A, Nath B, Kyereme F, Brehler M, Bukowy J, Coss D, Lupo JM, Phillips JJ, Ellingson BM, Krucoff MO, Mueller WM, Banerjee A, LaViolette PS. PMID: 38501824; PMCID: PMC11302944.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Quantification of T2-FLAIR Mismatch in Nonenhancing Diffuse Gliomas Using Digital Subtraction. AJNR Am J Neuroradiol. 2024 02 07; 45(2):188-197. Cho NS, Sanvito F, Le VL, Oshima S, Teraishi A, Yao J, Telesca D, Raymond C, Pope WB, Nghiemphu PL, Lai A, Cloughesy TF, Salamon N, Ellingson BM. PMID: 38238098; PMCID: PMC11285991.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    19. Single-nucleus expression characterization of non-enhancing region of recurrent high-grade glioma. Neurooncol Adv. 2024 Jan-Dec; 6(1):vdae005. Patel KS, Tessema KK, Kawaguchi R, Dudley L, Alvarado AG, Muthukrishnan SD, Perryman T, Hagiwara A, Swarup V, Liau LM, Wang AC, Yong W, Geschwind DH, Nakano I, Goldman SA, Everson RG, Ellingson BM, Kornblum HI. PMID: 38616896; PMCID: PMC11012612.
      View in: PubMed   Mentions:
    20. pH-Weighted amine chemical exchange saturation transfer echo planar imaging visualizes infiltrating glioblastoma cells. Neuro Oncol. 2024 01 05; 26(1):115-126. Patel KS, Yao J, Cho NS, Sanvito F, Tessema K, Alvarado A, Dudley L, Rodriguez F, Everson R, Cloughesy TF, Salamon N, Liau LM, Kornblum HI, Ellingson BM. PMID: 37591790; PMCID: PMC10768991.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    21. Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial. Nat Med. 2024 Jan; 30(1):302. Mellinghoff IK, Lu M, Wen PY, Taylor JW, Maher EA, Arrillaga-Romany I, Peters KB, Ellingson BM, Rosenblum MK, Chun S, Le K, Tassinari A, Choe S, Toubouti Y, Schoenfeld S, Pandya SS, Hassan I, Steelman L, Clarke JL, Cloughesy TF. PMID: 37400643; PMCID: PMC10803248.
      View in: PubMed   Mentions:    Fields:    
    22. PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group. Lancet Oncol. 2024 Jan; 25(1):e29-e41. Albert NL, Galldiks N, Ellingson BM, van den Bent MJ, Chang SM, Cicone F, de Groot J, Koh ES, Law I, Le Rhun E, Mair MJ, Minniti G, Rudà R, Scott AM, Short SC, Smits M, Suchorska B, Tolboom N, Traub-Weidinger T, Tonn JC, Verger A, Weller M, Wen PY, Preusser M. PMID: 38181810.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    23. Standardized brain tumor imaging protocols for clinical trials: current recommendations and tips for integration. Front Radiol. 2023; 3:1267615. Sanvito F, Kaufmann TJ, Cloughesy TF, Wen PY, Ellingson BM. PMID: 38152383; PMCID: PMC10751345.
      View in: PubMed   Mentions: 4  
    24. A framework for standardised tissue sampling and processing during resection of diffuse intracranial glioma: joint recommendations from four RANO groups. Lancet Oncol. 2023 11; 24(11):e438-e450. Karschnia P, Smits M, Reifenberger G, Le Rhun E, Ellingson BM, Galldiks N, Kim MM, Huse JT, Schnell O, Harter PN, Mohme M, Expert Rater Panel, von Baumgarten L, Albert NL, Huang RY, Mehta MP, van den Bent M, Weller M, Vogelbaum MA, Chang SM, Berger MS, Tonn JC. PMID: 37922934; PMCID: PMC10849105.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    25. Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways. Cancer Discov. 2023 11 01; 13(11):2370-2393. Venneti S, Kawakibi AR, Ji S, Waszak SM, Sweha SR, Mota M, Pun M, Deogharkar A, Chung C, Tarapore RS, Ramage S, Chi A, Wen PY, Arrillaga-Romany I, Batchelor TT, Butowski NA, Sumrall A, Shonka N, Harrison RA, de Groot J, Mehta M, Hall MD, Daghistani D, Cloughesy TF, Ellingson BM, Beccaria K, Varlet P, Kim MM, Umemura Y, Garton H, Franson A, Schwartz J, Jain R, Kachman M, Baum H, Burant CF, Mottl SL, Cartaxo RT, John V, Messinger D, Qin T, Peterson E, Sajjakulnukit P, Ravi K, Waugh A, Walling D, Ding Y, Xia Z, Schwendeman A, Hawes D, Yang F, Judkins AR, Wahl D, Lyssiotis CA, de la Nava D, Alonso MM, Eze A, Spitzer J, Schmidt SV, Duchatel RJ, Dun MD, Cain JE, Jiang L, Stopka SA, Baquer G, Regan MS, Filbin MG, Agar NYR, Zhao L, Kumar-Sinha C, Mody R, Chinnaiyan A, Kurokawa R, Pratt D, Yadav VN, Grill J, Kline C, Mueller S, Resnick A, Nazarian J, Allen JE, Odia Y, Gardner SL, Koschmann C. PMID: 37584601; PMCID: PMC10618742.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    26. Simultaneous quantification of perfusion, permeability, and leakage effects in brain gliomas using dynamic spin-and-gradient-echo echoplanar imaging MRI. Eur Radiol. 2024 May; 34(5):3087-3101. Sanvito F, Raymond C, Cho NS, Yao J, Hagiwara A, Orpilla J, Liau LM, Everson RG, Nghiemphu PL, Lai A, Prins R, Salamon N, Cloughesy TF, Ellingson BM. PMID: 37882836; PMCID: PMC11045669.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    27. Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma. J Neurooncol. 2023 Oct; 165(1):101-112. Strowd R, Ellingson B, Raymond C, Yao J, Wen PY, Ahluwalia M, Piotrowski A, Desai A, Clarke JL, Lieberman FS, Desideri S, Nabors LB, Ye X, Grossman S. PMID: 37864646; PMCID: PMC10863646.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCTClinical Trials
    28. Depth of Radiographic Response and Time to Tumor Regrowth Predicts Overall Survival Following Anti-VEGF Therapy in Recurrent Glioblastoma. Clin Cancer Res. 2023 10 13; 29(20):4186-4195. Ellingson BM, Hagiwara A, Morris CJ, Cho NS, Oshima S, Sanvito F, Oughourlian TC, Telesca D, Raymond C, Abrey LE, Garcia J, Aftab DT, Hessel C, Rachmilewitz Minei T, Harats D, Nathanson DA, Wen PY, Cloughesy TF. PMID: 37540556; PMCID: PMC10592195.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    29. RANO 2.0: Update to the Response Assessment in Neuro-Oncology Criteria for High- and Low-Grade Gliomas in Adults. J Clin Oncol. 2023 Nov 20; 41(33):5187-5199. Wen PY, van den Bent M, Youssef G, Cloughesy TF, Ellingson BM, Weller M, Galanis E, Barboriak DP, de Groot J, Gilbert MR, Huang R, Lassman AB, Mehta M, Molinaro AM, Preusser M, Rahman R, Shankar LK, Stupp R, Villanueva-Meyer JE, Wick W, Macdonald DR, Reardon DA, Vogelbaum MA, Chang SM. PMID: 37774317; PMCID: PMC10860967.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    30. NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdad124. Sim HW, Wachsmuth L, Barnes EH, Yip S, Koh ES, Hall M, Jennens R, Ashley DM, Verhaak RG, Heimberger AB, Rosenthal MA, Hovey EJ, Ellingson BM, Tognela A, Gan HK, Wheeler H, Back M, McDonald KL, Long A, Cuff K, Begbie S, Gedye C, Mislang A, Le H, Johnson MO, Kong BY, Simes JR, Lwin Z, Khasraw M. PMID: 37841696; PMCID: PMC10576515.
      View in: PubMed   Mentions: 3  
    31. Dendritic Cell Vaccination in Conjunction with a TLR Agonist Polarizes Interferon Immune Responses in Malignant Glioma Patients. Res Sq. 2023 Sep 12. Everson RG, Hugo W, Sun L, Antonios J, Lee A, Ding L, Bu M, Khattab S, Chavez C, Billingslea-Yoon E, Salazar A, Ellingson BM, Cloughesy TF, Liau LM, Prins RM. PMID: 37790490; PMCID: PMC10543402.
      View in: PubMed   Mentions:
    32. Diffusion histogram profiles predict molecular features of grade 4 in histologically lower-grade adult diffuse gliomas following WHO classification 2021. Eur Radiol. 2024 Feb; 34(2):1367-1375. Kurokawa R, Hagiwara A, Kurokawa M, Ellingson BM, Baba A, Moritani T. PMID: 37581661; PMCID: PMC10853353.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    33. Small pretreatment lesion size and high sphericity as favorable prognostic factors after laser interstitial thermal therapy in brain metastases. J Neurosurg. 2024 Feb 01; 140(2):338-349. Sanvito F, Telesca D, Cho NS, Sayari JT, Nagaraj R, Raymond C, Rana S, Patel K, Mozaffari K, Unterberger AA, Khanlou N, Magaki S, Pouratian N, Everson RG, Yang I, Kim W, Ellingson BM. PMID: 37542437.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    34. Reply to Di Nunno et al. concerning objective response rates targets for recurrent glioblastoma clinical trials: Toward surrogate endpoints for phase II trials in patients with recurrent glioblastoma. Neuro Oncol. 2023 08 03; 25(8):1548-1549. Ellingson BM, Wen PY, Cloughesy TF. PMID: 37167013; PMCID: PMC10398798.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    35. National Cancer Institute Collaborative Workshop on Shaping the Landscape of Brain Metastases Research: challenges and recommended priorities. Lancet Oncol. 2023 08; 24(8):e344-e354. Kim MM, Mehta MP, Smart DK, Steeg PS, Hong JA, Espey MG, Prasanna PG, Crandon L, Hodgdon C, Kozak N, Armstrong TS, Morikawa A, Willmarth N, Tanner K, Boire A, Gephart MH, Margolin KA, Hattangadi-Gluth J, Tawbi H, Trifiletti DM, Chung C, Basu-Roy U, Burns R, Oliva ICG, Aizer AA, Anders CK, Davis J, Ahluwalia MS, Chiang V, Li J, Kotecha R, Formenti SC, Ellingson BM, Gondi V, Sperduto PW, Barnholtz-Sloan JS, Rodon J, Lee EQ, Khasraw M, Yeboa DN, Brastianos PK, Galanis E, Coleman CN, Ahmed MM. PMID: 37541280; PMCID: PMC10681121.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    36. Cortical thickness, gray-white matter contrast, and intracortical myelin in first-episode schizophrenia patients treated with long-acting paliperidone palmitate versus oral antipsychotics. Psychiatry Res. 2023 08; 326:115364. Wang C, Tishler TA, Nuechterlein KH, Ellingson BM. PMID: 37494877.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    37. Change in volumetric tumor growth rate after cytotoxic therapy is predictive of overall survival in recurrent glioblastoma. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdad084. Oshima S, Hagiwara A, Raymond C, Wang C, Cho NS, Lu J, Eldred BSC, Nghiemphu PL, Lai A, Telesca D, Salamon N, Cloughesy TF, Ellingson BM. PMID: 37554221; PMCID: PMC10406419.
      View in: PubMed   Mentions: 1  
    38. The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I-III Studies. Curr Oncol Rep. 2023 09; 25(9):1047-1055. Cho NS, Wong WK, Nghiemphu PL, Cloughesy TF, Ellingson BM. PMID: 37402043; PMCID: PMC10474988.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    39. Spinal Cord Signal Intensity Predicts Functional Outcomes in the Operative Management of Degenerative Cervical Myelopathy. Clin Spine Surg. 2023 12 01; 36(10):438-443. Firempong GK, Sheppard WL, Gelfand Y, Ellingson BM, Holly LT. PMID: 38031316; PMCID: PMC10691530.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    40. Multi-nuclear sodium, diffusion, and perfusion MRI in human gliomas. J Neurooncol. 2023 Jun; 163(2):417-427. Cho NS, Sanvito F, Thakuria S, Wang C, Hagiwara A, Nagaraj R, Oshima S, Lopez Kolkovsky AL, Lu J, Raymond C, Liau LM, Everson RG, Patel KS, Kim W, Yang I, Bergsneider M, Nghiemphu PL, Lai A, Nathanson DA, Cloughesy TF, Ellingson BM. PMID: 37294422; PMCID: PMC10322966.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    41. Targeting the IL4 receptor with MDNA55 in patients with recurrent glioblastoma: Results of a phase IIb trial. Neuro Oncol. 2023 06 02; 25(6):1085-1097. Sampson JH, Singh Achrol A, Aghi MK, Bankiewicz K, Bexon M, Brem S, Brenner A, Chandhasin C, Chowdhary S, Coello M, Ellingson BM, Floyd JR, Han S, Kesari S, Mardor Y, Merchant F, Merchant N, Randazzo D, Vogelbaum M, Vrionis F, Wembacher-Schroeder E, Zabek M, Butowski N. PMID: 36640127; PMCID: PMC10237418.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    42. Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival. Neuro Oncol. 2023 06 02; 25(6):1017-1028. Ellingson BM, Wen PY, Chang SM, van den Bent M, Vogelbaum MA, Li G, Li S, Kim J, Youssef G, Wick W, Lassman AB, Gilbert MR, de Groot JF, Weller M, Galanis E, Cloughesy TF. PMID: 36617262; PMCID: PMC10237425.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    43. A single-institution retrospective analysis of pathologically determined malignant transformation in IDH mutant glioma patients. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdad036. Liu V, Wetzel EA, Eldred BSC, Zapanta Rinonos S, Prins TJ, Khanlou N, Liau LM, Chong R, Nghiemphu PL, Cloughesy TF, Ellingson BM, Lai A. PMID: 37152809; PMCID: PMC10162112.
      View in: PubMed   Mentions: 2  
    44. Evaluation of Standard Response Assessment in Neuro-Oncology, Modified Response Assessment in Neuro-Oncology, and Immunotherapy Response Assessment in Neuro-Oncology in Newly Diagnosed and Recurrent Glioblastoma. J Clin Oncol. 2023 06 10; 41(17):3160-3171. Youssef G, Rahman R, Bay C, Wang W, Lim-Fat MJ, Arnaout O, Bi WL, Cagney DN, Chang YS, Cloughesy TF, DeSalvo M, Ellingson BM, Flood TF, Gerstner ER, Gonzalez Castro LN, Guenette JP, Kim AE, Lee EQ, McFaline-Figueroa JR, Potter CA, Reardon DA, Huang RY, Wen PY. PMID: 37027809.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    45. Prospective, randomized, multicenter clinical trial evaluating longitudinal changes in brain function and microstructure in first-episode schizophrenia patients treated with long-acting injectable paliperidone palmitate versus oral antipsychotics. Schizophr Res. 2023 05; 255:222-232. Wang C, Tishler TA, Oughourlian T, Nuechterlein KH, de la Fuente-Sandoval C, Ellingson BM. PMID: 37019033.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    46. Effect of treatment with paliperidone palmitate versus oral antipsychotics on frontal lobe intracortical myelin volume in participants with recent-onset schizophrenia: Magnetic resonance imaging results from the DREaM study. Schizophr Res. 2023 05; 255:195-202. Tishler TA, Ellingson BM, Salvadore G, Baker P, Turkoz I, Subotnik KL, de la Fuente-Sandoval C, Nuechterlein KH, Alphs L. PMID: 37004331.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    47. Retrospective examination of pseudoprogression in IDH mutant gliomas. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdad028. Wetzel EA, Farrell MJ, Eldred BSC, Liu V, Saha I, Zapanta Rinonos S, Prins T, Li T, Cao M, Hegde J, Kaprealian T, Khanlou N, Liau LM, Nghiemphu PL, Cloughesy TF, Chong RA, Ellingson BM, Lai A. PMID: 37128507; PMCID: PMC10148681.
      View in: PubMed   Mentions: 1  
    48. Harnessing imaging tools to guide immunotherapy trials: summary from the National Cancer Institute Cancer Imaging Steering Committee workshop. Lancet Oncol. 2023 03; 24(3):e133-e143. Shankar LK, Schöder H, Sharon E, Wolchok J, Knopp MV, Wahl RL, Ellingson BM, Hall NC, Yaffe MJ, Towbin AJ, Farwell MD, Pryma D, Poussaint TY, Wright CL, Schwartz L, Harisinghani M, Mahmood U, Wu AM, Leung D, de Vries EGE, Tang Y, Beach G, Reeves SA. PMID: 36858729; PMCID: PMC10119769.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    49. Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial. Nat Med. 2023 03; 29(3):615-622. Mellinghoff IK, Lu M, Wen PY, Taylor JW, Maher EA, Arrillaga-Romany I, Peters KB, Ellingson BM, Rosenblum MK, Chun S, Le K, Tassinari A, Choe S, Toubouti Y, Schoenfeld S, Pandya SS, Hassan I, Steelman L, Clarke JL, Cloughesy TF. PMID: 36823302; PMCID: PMC10313524.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCTClinical Trials
    50. Multi-Parametric Radiomic Model to Predict 1p/19q Co-Deletion in Patients with IDH-1 Mutant Glioma: Added Value to the T2-FLAIR Mismatch Sign. Cancers (Basel). 2023 Feb 07; 15(4). Kihira S, Derakhshani A, Leung M, Mahmoudi K, Bauer A, Zhang H, Polson J, Arnold C, Tsankova NM, Hormigo A, Salehi B, Pham N, Ellingson BM, Cloughesy TF, Nael K. PMID: 36831380; PMCID: PMC9954034.
      View in: PubMed   Mentions: 5  
    51. Structural Relationship between Cerebral Gray and White Matter Alterations in Degenerative Cervical Myelopathy. Tomography. 2023 01 31; 9(1):315-327. Wang C, Sanvito F, Oughourlian TC, Islam S, Salamon N, Holly LT, Ellingson BM. PMID: 36828377; PMCID: PMC9961386.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    52. Author Correction: Federated learning enables big data for rare cancer boundary detection. Nat Commun. 2023 Jan 26; 14(1):436. Pati S, Baid U, Edwards B, Sheller M, Wang SH, Reina GA, Foley P, Gruzdev A, Karkada D, Davatzikos C, Sako C, Ghodasara S, Bilello M, Mohan S, Vollmuth P, Brugnara G, Preetha CJ, Sahm F, Maier-Hein K, Zenk M, Bendszus M, Wick W, Calabrese E, Rudie J, Villanueva-Meyer J, Cha S, Ingalhalikar M, Jadhav M, Pandey U, Saini J, Garrett J, Larson M, Jeraj R, Currie S, Frood R, Fatania K, Huang RY, Chang K, Balaña C, Capellades J, Puig J, Trenkler J, Pichler J, Necker G, Haunschmidt A, Meckel S, Shukla G, Liem S, Alexander GS, Lombardo J, Palmer JD, Flanders AE, Dicker AP, Sair HI, Jones CK, Venkataraman A, Jiang M, So TY, Chen C, Heng PA, Dou Q, Kozubek M, Lux F, Michálek J, Matula P, Kerkovský M, Koprivová T, Dostál M, Vybíhal V, Vogelbaum MA, Mitchell JR, Farinhas J, Maldjian JA, Yogananda CGB, Pinho MC, Reddy D, Holcomb J, Wagner BC, Ellingson BM, Cloughesy TF, Raymond C, Oughourlian T, Hagiwara A, Wang C, To MS, Bhardwaj S, Chong C, Agzarian M, Falcão AX, Martins SB, Teixeira BCA, Sprenger F, Menotti D, Lucio DR, LaMontagne P, Marcus D, Wiestler B, Kofler F, Ezhov I, Metz M, Jain R, Lee M, Lui YW, McKinley R, Slotboom J, Radojewski P, Meier R, Wiest R, Murcia D, Fu E, Haas R, Thompson J, Ormond DR, Badve C, Sloan AE, Vadmal V, Waite K, Colen RR, Pei L, Ak M, Srinivasan A, Bapuraj JR, Rao A, Wang N, Yoshiaki O, Moritani T, Turk S, Lee J, Prabhudesai S, Morón F, Mandel J, Kamnitsas K, Glocker B, Dixon LVM, Williams M, Zampakis P, Panagiotopoulos V, Tsiganos P, Alexiou S, Haliassos I, Zacharaki EI, Moustakas K, Kalogeropoulou C, Kardamakis DM, Choi YS, Lee SK, Chang JH, Ahn SS, Luo B, Poisson L, Wen N, Tiwari P, Verma R, Bareja R, Yadav I, Chen J, Kumar N, Smits M, van der Voort SR, Alafandi A, Incekara F, Wijnenga MMJ, Kapsas G, Gahrmann R, Schouten JW, Dubbink HJ, Vincent AJPE, van den Bent MJ, French PJ, Klein S, Yuan Y, Sharma S, Tseng TC, Adabi S, Niclou SP, Keunen O, Hau AC, Vallières M, Fortin D, Lepage M, Landman B, Ramadass K, Xu K, Chotai S, Chambless LB, Mistry A, Thompson RC, Gusev Y, Bhuvaneshwar K, Sayah A, Bencheqroun C, Belouali A, Madhavan S, Booth TC, Chelliah A, Modat M, Shuaib H, Dragos C, Abayazeed A, Kolodziej K, Hill M, Abbassy A, Gamal S, Mekhaimar M, Qayati M, Reyes M, Park JE, Yun J, Kim HS, Mahajan A, Muzi M, Benson S, Beets-Tan RGH, Teuwen J, Herrera-Trujillo A, Trujillo M, Escobar W, Abello A, Bernal J, Gómez J, Choi J, Baek S, Kim Y, Ismael H, Allen B, Buatti JM, Kotrotsou A, Li H, Weiss T, Weller M, Bink A, Pouymayou B, Shaykh HF, Saltz J, Prasanna P, Shrestha S, Mani KM, Payne D, Kurc T, Pelaez E, Franco-Maldonado H, Loayza F, Quevedo S, Guevara P, Torche E, Mendoza C, Vera F, Ríos E, López E, Velastin SA, Ogbole G, Soneye M, Oyekunle D, Odafe-Oyibotha O, Osobu B, Shu'aibu M, Dorcas A, Dako F, Simpson AL, Hamghalam M, Peoples JJ, Hu R, Tran A, Cutler D, Moraes FY, Boss MA, Gimpel J, Veettil DK, Schmidt K, Bialecki B, Marella S, Price C, Cimino L, Apgar C, Shah P, Menze B, Barnholtz-Sloan JS, Martin J, Bakas S. PMID: 36702828; PMCID: PMC9879935.
      View in: PubMed   Mentions:    Fields:    
    53. Synthesizing MR Image Contrast Enhancement Using 3D High-Resolution ConvNets. IEEE Trans Biomed Eng. 2023 02; 70(2):401-412. Chen C, Raymond C, Speier W, Jin X, Cloughesy TF, Enzmann D, Ellingson BM, Arnold CW. PMID: 35853075; PMCID: PMC9928432.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    54. NS-HGlio: A generalizable and repeatable HGG segmentation and volumetric measurement AI algorithm for the longitudinal MRI assessment to inform RANO in trials and clinics. Neurooncol Adv. 2023 Jan-Dec; 5(1):vdac184. Abayazeed AH, Abbassy A, Müeller M, Hill M, Qayati M, Mohamed S, Mekhaimar M, Raymond C, Dubey P, Nael K, Rohatgi S, Kapare V, Kulkarni A, Shiang T, Kumar A, Andratschke N, Willmann J, Brawanski A, De Jesus R, Tuna I, Fung SH, Landolfi JC, Ellingson BM, Reyes M. PMID: 36685009; PMCID: PMC9850874.
      View in: PubMed   Mentions: 3  
    55. A multi-omic brain gut microbiome signature differs between IBS subjects with different bowel habits. Neuropharmacology. 2023 03 01; 225:109381. Sarnoff RP, Bhatt RR, Osadchiy V, Dong T, Labus JS, Kilpatrick LA, Chen Z, Subramanyam V, Zhang Y, Ellingson BM, Naliboff B, Chang L, Mayer EA, Gupta A. PMID: 36539012; PMCID: PMC10711989.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    56. Federated learning enables big data for rare cancer boundary detection. Nat Commun. 2022 12 05; 13(1):7346. Pati S, Baid U, Edwards B, Sheller M, Wang SH, Reina GA, Foley P, Gruzdev A, Karkada D, Davatzikos C, Sako C, Ghodasara S, Bilello M, Mohan S, Vollmuth P, Brugnara G, Preetha CJ, Sahm F, Maier-Hein K, Zenk M, Bendszus M, Wick W, Calabrese E, Rudie J, Villanueva-Meyer J, Cha S, Ingalhalikar M, Jadhav M, Pandey U, Saini J, Garrett J, Larson M, Jeraj R, Currie S, Frood R, Fatania K, Huang RY, Chang K, Balaña C, Capellades J, Puig J, Trenkler J, Pichler J, Necker G, Haunschmidt A, Meckel S, Shukla G, Liem S, Alexander GS, Lombardo J, Palmer JD, Flanders AE, Dicker AP, Sair HI, Jones CK, Venkataraman A, Jiang M, So TY, Chen C, Heng PA, Dou Q, Kozubek M, Lux F, Michálek J, Matula P, Kerkovský M, Koprivová T, Dostál M, Vybíhal V, Vogelbaum MA, Mitchell JR, Farinhas J, Maldjian JA, Yogananda CGB, Pinho MC, Reddy D, Holcomb J, Wagner BC, Ellingson BM, Cloughesy TF, Raymond C, Oughourlian T, Hagiwara A, Wang C, To MS, Bhardwaj S, Chong C, Agzarian M, Falcão AX, Martins SB, Teixeira BCA, Sprenger F, Menotti D, Lucio DR, LaMontagne P, Marcus D, Wiestler B, Kofler F, Ezhov I, Metz M, Jain R, Lee M, Lui YW, McKinley R, Slotboom J, Radojewski P, Meier R, Wiest R, Murcia D, Fu E, Haas R, Thompson J, Ormond DR, Badve C, Sloan AE, Vadmal V, Waite K, Colen RR, Pei L, Ak M, Srinivasan A, Bapuraj JR, Rao A, Wang N, Yoshiaki O, Moritani T, Turk S, Lee J, Prabhudesai S, Morón F, Mandel J, Kamnitsas K, Glocker B, Dixon LVM, Williams M, Zampakis P, Panagiotopoulos V, Tsiganos P, Alexiou S, Haliassos I, Zacharaki EI, Moustakas K, Kalogeropoulou C, Kardamakis DM, Choi YS, Lee SK, Chang JH, Ahn SS, Luo B, Poisson L, Wen N, Tiwari P, Verma R, Bareja R, Yadav I, Chen J, Kumar N, Smits M, van der Voort SR, Alafandi A, Incekara F, Wijnenga MMJ, Kapsas G, Gahrmann R, Schouten JW, Dubbink HJ, Vincent AJPE, van den Bent MJ, French PJ, Klein S, Yuan Y, Sharma S, Tseng TC, Adabi S, Niclou SP, Keunen O, Hau AC, Vallières M, Fortin D, Lepage M, Landman B, Ramadass K, Xu K, Chotai S, Chambless LB, Mistry A, Thompson RC, Gusev Y, Bhuvaneshwar K, Sayah A, Bencheqroun C, Belouali A, Madhavan S, Booth TC, Chelliah A, Modat M, Shuaib H, Dragos C, Abayazeed A, Kolodziej K, Hill M, Abbassy A, Gamal S, Mekhaimar M, Qayati M, Reyes M, Park JE, Yun J, Kim HS, Mahajan A, Muzi M, Benson S, Beets-Tan RGH, Teuwen J, Herrera-Trujillo A, Trujillo M, Escobar W, Abello A, Bernal J, Gómez J, Choi J, Baek S, Kim Y, Ismael H, Allen B, Buatti JM, Kotrotsou A, Li H, Weiss T, Weller M, Bink A, Pouymayou B, Shaykh HF, Saltz J, Prasanna P, Shrestha S, Mani KM, Payne D, Kurc T, Pelaez E, Franco-Maldonado H, Loayza F, Quevedo S, Guevara P, Torche E, Mendoza C, Vera F, Ríos E, López E, Velastin SA, Ogbole G, Soneye M, Oyekunle D, Odafe-Oyibotha O, Osobu B, Shu'aibu M, Dorcas A, Dako F, Simpson AL, Hamghalam M, Peoples JJ, Hu R, Tran A, Cutler D, Moraes FY, Boss MA, Gimpel J, Veettil DK, Schmidt K, Bialecki B, Marella S, Price C, Cimino L, Apgar C, Shah P, Menze B, Barnholtz-Sloan JS, Martin J, Bakas S. PMID: 36470898; PMCID: PMC9722782.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    57. Qualitative and quantitative evaluation for the heterogeneity of cortical tubers using structural imaging and diffusion-weighted imaging to predict the epileptogenicity in tuberous sclerosis complex patients. Neuroradiology. 2023 Apr; 65(4):845-853. Yogi A, Hirata Y, Linetsky M, Ellingson BM, Salamon N. PMID: 36456893.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    58. Reproducible Microstructural Changes in the Brain Associated With the Presence and Severity of Urologic Chronic Pelvic Pain Syndrome (UCPPS): A 3-Year Longitudinal Diffusion Tensor Imaging Study From the MAPP Network. J Pain. 2023 04; 24(4):627-642. Wang C, Kutch JJ, Labus JS, Yang CC, Harris RE, Mayer EA, Ellingson BM. PMID: 36435486; PMCID: PMC10676766.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    59. A multi-reader comparison of normal-appearing white matter normalization techniques for perfusion and diffusion MRI in brain tumors. Neuroradiology. 2023 Mar; 65(3):559-568. Cho NS, Hagiwara A, Sanvito F, Ellingson BM. PMID: 36301349; PMCID: PMC9905164.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    60. Alternative RNA splicing modulates ribosomal composition and determines the spatial phenotype of glioblastoma cells. Nat Cell Biol. 2022 10; 24(10):1541-1557. Larionova TD, Bastola S, Aksinina TE, Anufrieva KS, Wang J, Shender VO, Andreev DE, Kovalenko TF, Arapidi GP, Shnaider PV, Kazakova AN, Latyshev YA, Tatarskiy VV, Shtil AA, Moreau P, Giraud F, Li C, Wang Y, Rubtsova MP, Dontsova OA, Condro M, Ellingson BM, Shakhparonov MI, Kornblum HI, Nakano I, Pavlyukov MS. PMID: 36192632; PMCID: PMC10026424.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    61. Regional Cerebral Small Vessel Disease (rCSVD) Score: A clinical MRI grading system validated in a stroke cohort. J Clin Neurosci. 2022 Nov; 105:131-136. Hazany S, Nguyen KL, Lee M, Zhang A, Mokhtar P, Crossley A, Luthra S, Butani P, Dergalust S, Ellingson B, Hinman JD. PMID: 36183571; PMCID: PMC10163829.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    62. Evolution of brain functional plasticity associated with increasing symptom severity in degenerative cervical myelopathy. EBioMedicine. 2022 Oct; 84:104255. Wang C, Ellingson BM, Oughourlian TC, Salamon N, Holly LT. PMID: 36116214; PMCID: PMC9483733.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    63. Low rank off-resonance correction for double half-echo k-space acquisitions. Magn Reson Imaging. 2022 12; 94:43-47. Bydder M, Ali F, Saucedo A, Ghodrati V, Samsonov A, Akhtari M, Wang C, Hagiwara A, Yao J, Ellingson B. PMID: 36113740.
      View in: PubMed   Mentions:    Fields:    
    64. Dispersion of cognitive performance test scores on the MATRICS Consensus Cognitive Battery: A different perspective. Schizophr Res Cogn. 2022 Dec; 30:100270. Williamson DJ, Nuechterlein KH, Tishler T, Ventura J, Ellingson BM, Turkoz I, Keefe RSE, Alphs L. PMID: 36111288; PMCID: PMC9468588.
      View in: PubMed   Mentions:
    65. Relapse patterns and radiation dose exposure in IDH wild-type glioblastoma at first radiographic recurrence following chemoradiation. J Neurooncol. 2022 Oct; 160(1):115-125. Shidoh S, Savjani RR, Cho NS, Ullman HE, Hagiwara A, Raymond C, Lai A, Nghiemphu PL, Liau LM, Pope WB, Cloughesy TF, Kaprealian TB, Salamon N, Ellingson BM. PMID: 36053452; PMCID: PMC9622513.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    66. Early volumetric, perfusion, and diffusion MRI changes after mutant isocitrate dehydrogenase (IDH) inhibitor treatment in IDH1-mutant gliomas. Neurooncol Adv. 2022 Jan-Dec; 4(1):vdac124. Cho NS, Hagiwara A, Eldred BSC, Raymond C, Wang C, Sanvito F, Lai A, Nghiemphu P, Salamon N, Steelman L, Hassan I, Cloughesy TF, Ellingson BM. PMID: 36033919; PMCID: PMC9400453.
      View in: PubMed   Mentions: 6  
    67. Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors. Neuro Oncol. 2022 08 01; 24(8):1219-1229. Ellingson BM, Gerstner ER, Lassman AB, Chung C, Colman H, Cole PE, Leung D, Allen JE, Ahluwalia MS, Boxerman J, Brown M, Goldin J, Nduom E, Hassan I, Gilbert MR, Mellinghoff IK, Weller M, Chang S, Arons D, Meehan C, Selig W, Tanner K, Alfred Yung WK, van den Bent M, Wen PY, Cloughesy TF. PMID: 35380705; PMCID: PMC9340639.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    68. Incidence, molecular characteristics, and imaging features of "clinically-defined pseudoprogression" in newly diagnosed glioblastoma treated with chemoradiation. J Neurooncol. 2022 Sep; 159(3):509-518. Hagiwara A, Schlossman J, Shabani S, Raymond C, Tatekawa H, Abrey LE, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason WP, Wick W, Cloughesy TF, Ellingson BM. PMID: 35842871.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    69. Amine-weighted chemical exchange saturation transfer magnetic resonance imaging in brain tumors. NMR Biomed. 2023 06; 36(6):e4785. Cho NS, Hagiwara A, Yao J, Nathanson DA, Prins RM, Wang C, Raymond C, Desousa BR, Divakaruni A, Morrow DH, Nghiemphu PL, Lai A, Liau LM, Everson RG, Salamon N, Pope WB, Cloughesy TF, Ellingson BM. PMID: 35704275.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    70. Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors. Neuro Oncol. 2022 06 01; 24(6):1020-1028. Hagiwara A, Oughourlian TC, Cho NS, Schlossman J, Wang C, Yao J, Raymond C, Everson R, Patel K, Mareninov S, Rodriguez FJ, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Prins RM, Cloughesy TF, Ellingson BM. PMID: 34865129; PMCID: PMC9159421.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    71. Characterization of Cognitive Function in Survivors of Diffuse Gliomas Using Morphometric Correlation Networks. Tomography. 2022 05 26; 8(3):1437-1452. Wang C, Cho NS, Dyk KV, Islam S, Raymond C, Choi J, Salamon N, Pope WB, Lai A, Cloughesy TF, Nghiemphu PL, Ellingson BM. PMID: 35736864; PMCID: PMC9229761.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    72. Sex-specific brain microstructural reorganization in irritable bowel syndrome. Pain. 2023 02 01; 164(2):292-304. Labus JS, Wang C, Mayer EA, Gupta A, Oughourlian T, Kilpatrick L, Tillisch K, Chang L, Naliboff B, Ellingson BM. PMID: 35639426; PMCID: PMC9691795.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    73. Diagnostic and Prognostic Value of pH- and Oxygen-Sensitive Magnetic Resonance Imaging in Glioma: A Retrospective Study. Cancers (Basel). 2022 May 20; 14(10). Yao J, Hagiwara A, Oughourlian TC, Wang C, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 35626127; PMCID: PMC9139712.
      View in: PubMed   Mentions: 2  
    74. Daily functioning in glioma survivors: associations with cognitive function, psychological factors and quality of life. CNS Oncol. 2022 06 01; 11(2):CNS84. Van Dyk K, Wall L, Heimberg BF, Choi J, Raymond C, Wang C, Lai A, Cloughesy TF, Ellingson BM, Nghiemphu P. PMID: 35583041; PMCID: PMC9134930.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    75. Volumetric measurements are preferred in the evaluation of mutant IDH inhibition in non-enhancing diffuse gliomas: Evidence from a phase I trial of ivosidenib. Neuro Oncol. 2022 05 04; 24(5):770-778. Ellingson BM, Kim GHJ, Brown M, Lee J, Salamon N, Steelman L, Hassan I, Pandya SS, Chun S, Linetsky M, Yoo B, Wen PY, Mellinghoff IK, Goldin J, Cloughesy TF. PMID: 34751786; PMCID: PMC9071341.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    76. Radiographic Response Assessment Strategies for Early-Phase Brain Trials in Complex Tumor Types and Drug Combinations: from Digital "Flipbooks" to Control Systems Theory. Neurotherapeutics. 2022 10; 19(6):1855-1868. Ellingson BM, Levin VA, Cloughesy TF. PMID: 35451676; PMCID: PMC9723080.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    77. Recovery of Supraspinal Microstructural Integrity and Connectivity in Patients Undergoing Surgery for Degenerative Cervical Myelopathy. Neurosurgery. 2022 04 01; 90(4):447-456. Wang C, Ellingson BM, Salamon N, Holly LT. PMID: 35076030; PMCID: PMC9514753.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    78. Paradoxical Association Between Relative Cerebral Blood Volume Dynamics Following Chemoradiation and Increased Progression-Free Survival in Newly Diagnosed IDH Wild-Type MGMT Promoter Methylated Glioblastoma With Measurable Disease. Front Oncol. 2022; 12:849993. Goldman J, Hagiwara A, Yao J, Raymond C, Ong C, Bakhti R, Kwon E, Farhat M, Torres C, Erickson LG, Curl BJ, Lee M, Pope WB, Salamon N, Nghiemphu PL, Ji M, Eldred BS, Liau LM, Lai A, Cloughesy TF, Chung C, Ellingson BM. PMID: 35371980; PMCID: PMC8964348.
      View in: PubMed   Mentions: 2  
    79. Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRI. Sci Rep. 2022 01 20; 12(1):1078. Hagiwara A, Tatekawa H, Yao J, Raymond C, Everson R, Patel K, Mareninov S, Yong WH, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 35058510; PMCID: PMC8776874.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    80. Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome. 2021 11 30; 9(1):236. Jacobs JP, Gupta A, Bhatt RR, Brawer J, Gao K, Tillisch K, Lagishetty V, Firth R, Gudleski GD, Ellingson BM, Labus JS, Naliboff BD, Lackner JM, Mayer EA. PMID: 34847963; PMCID: PMC8630837.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    81. "Aerobic glycolytic imaging" of human gliomas using combined pH-, oxygen-, and perfusion-weighted magnetic resonance imaging. Neuroimage Clin. 2021; 32:102882. Hagiwara A, Yao J, Raymond C, Cho NS, Everson R, Patel K, Morrow DH, Desousa BR, Mareninov S, Chun S, Nathanson DA, Yong WH, Andrei G, Divakaruni AS, Salamon N, Pope WB, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 34911188; PMCID: PMC8609049.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    82. Sex-Dependent Cortical Volume Changes in Patients with Degenerative Cervical Myelopathy. J Clin Med. 2021 Sep 01; 10(17). Oughourlian TC, Wang C, Salamon N, Holly LT, Ellingson BM. PMID: 34501413; PMCID: PMC8432178.
      View in: PubMed   Mentions: 4  
    83. Therapeutic Response Assessment of High-Grade Gliomas During Early-Phase Drug Development in the Era of Molecular and Immunotherapies. Cancer J. 2021 Sep-Oct 01; 27(5):395-403. Ellingson BM, Wen PY, Cloughesy TF. PMID: 34570454; PMCID: PMC8480435.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    84. Sodium MR Neuroimaging. AJNR Am J Neuroradiol. 2021 11; 42(11):1920-1926. Hagiwara A, Bydder M, Oughourlian TC, Yao J, Salamon N, Jahan R, Villablanca JP, Enzmann DR, Ellingson BM. PMID: 34446457; PMCID: PMC8583254.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    85. Characterization of cognitive function in survivors of diffuse gliomas using resting-state functional MRI (rs-fMRI). Brain Imaging Behav. 2022 Feb; 16(1):239-251. Wang C, Van Dyk K, Cho N, Raymond C, Choi J, Salamon N, Pope WB, Lai A, Cloughesy TF, Nghiemphu PL, Ellingson BM. PMID: 34350525; PMCID: PMC8825610.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    86. Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imaging. Sci Rep. 2021 07 22; 11(1):15011. Akbari H, Kazerooni AF, Ware JB, Mamourian E, Anderson H, Guiry S, Sako C, Raymond C, Yao J, Brem S, O'Rourke DM, Desai AS, Bagley SJ, Ellingson BM, Davatzikos C, Nabavizadeh A. PMID: 34294864; PMCID: PMC8298590.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    87. A study of 3D radial density adapted trajectories for sodium imaging. Magn Reson Imaging. 2021 11; 83:89-95. Bydder M, Ali F, Saucedo A, Hagiwara A, Wang C, Pham AD, Yao J, Ellingson BM. PMID: 34271088.
      View in: PubMed   Mentions: 1     Fields:    
    88. Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG). Neuro Oncol. 2021 07 01; 23(7):1056-1071. Barajas RF, Politi LS, Anzalone N, Schöder H, Fox CP, Boxerman JL, Kaufmann TJ, Quarles CC, Ellingson BM, Auer D, Andronesi OC, Ferreri AJM, Mrugala MM, Grommes C, Neuwelt EA, Ambady P, Rubenstein JL, Illerhaus G, Nagane M, Batchelor TT, Hu LS. PMID: 33560416; PMCID: PMC8248856.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    89. Validation of diffusion MRI as a biomarker for efficacy using randomized phase III trial of bevacizumab with or without VB-111 in recurrent glioblastoma. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdab082. Ellingson BM, Patel K, Wang C, Raymond C, Brenner A, de Groot JF, Butowski NA, Zach L, Campian JL, Schlossman J, Rizvi S, Cohen YC, Lowenton-Spier N, Minei TR, Shmueli SF, Wen PY, Cloughesy TF. PMID: 34377989; PMCID: PMC8350152.
      View in: PubMed   Mentions: 3  
    90. Worse prognosis for IDH wild-type diffuse gliomas with larger residual biological tumor burden. Ann Nucl Med. 2021 Sep; 35(9):1022-1029. Tatekawa H, Uetani H, Hagiwara A, Bahri S, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. PMID: 34121166.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    91. Supraspinal functional and structural plasticity in patients undergoing surgery for degenerative cervical myelopathy. J Neurosurg Spine. 2021 08 01; 35(2):185-193. Wang C, Ellingson BM, Islam S, Laiwalla A, Salamon N, Holly LT. PMID: 34116506; PMCID: PMC9675984.
      View in: PubMed   Mentions: 6     Fields:    
    92. Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial. Clin Cancer Res. 2021 08 15; 27(16):4491-4499. Mellinghoff IK, Penas-Prado M, Peters KB, Burris HA, Maher EA, Janku F, Cote GM, de la Fuente MI, Clarke JL, Ellingson BM, Chun S, Young RJ, Liu H, Choe S, Lu M, Le K, Hassan I, Steelman L, Pandya SS, Cloughesy TF, Wen PY. PMID: 34078652; PMCID: PMC8364866.
      View in: PubMed   Mentions: 93     Fields:    Translation:HumansCTClinical Trials
    93. Cortical morphometric correlational networks associated with cognitive deficits in first episode schizophrenia. Schizophr Res. 2021 05; 231:179-188. Wang C, Oughourlian T, Tishler TA, Anwar F, Raymond C, Pham AD, Perschon A, Villablanca JP, Ventura J, Subotnik KL, Nuechterlein KH, Ellingson BM. PMID: 33872855.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    94. Modified RANO, Immunotherapy RANO, and Standard RANO Response to Convection-Enhanced Delivery of IL4R-Targeted Immunotoxin MDNA55 in Recurrent Glioblastoma. Clin Cancer Res. 2021 07 15; 27(14):3916-3925. Ellingson BM, Sampson J, Achrol AS, Aghi MK, Bankiewicz K, Wang C, Bexon M, Brem S, Brenner A, Chowdhary S, Floyd JR, Han S, Kesari S, Randazzo D, Vogelbaum MA, Vrionis F, Zabek M, Butowski N, Coello M, Merchant N, Merchant F. PMID: 33863808; PMCID: PMC8282697.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCTClinical Trials
    95. Unique challenges for glioblastoma immunotherapy-discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank. Neuro Oncol. 2021 03 25; 23(3):356-375. Chuntova P, Chow F, Watchmaker PB, Galvez M, Heimberger AB, Newell EW, Diaz A, DePinho RA, Li MO, Wherry EJ, Mitchell D, Terabe M, Wainwright DA, Berzofsky JA, Herold-Mende C, Heath JR, Lim M, Margolin KA, Chiocca EA, Kasahara N, Ellingson BM, Brown CE, Chen Y, Fecci PE, Reardon DA, Dunn GP, Liau LM, Costello JF, Wick W, Cloughesy T, Timmer WC, Wen PY, Prins RM, Platten M, Okada H. PMID: 33367885; PMCID: PMC7992879.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    96. ADC, D, f dataset calculated through the simplified IVIM model, with MGMT promoter methylation, age, and ECOG, in 38 patients with wildtype IDH glioblastoma. Data Brief. 2021 Apr; 35:106950. Maralani PJ, Myrehaug S, Mehrabian H, Chan AK, Wintermark M, Heyn C, Conklin J, Ellingson BM, Rahimi S, Lau AZ, Tseng CL, Soliman H, Detsky J, Daghighi S, Keith J, Munoz DG, Das S, Atenafu EG, Lipsman N, Perry J, Stanisz G, Sahgal A. PMID: 33850982; PMCID: PMC8039816.
      View in: PubMed   Mentions: 2  
    97. Preferential tumor localization in relation to 18F-FDOPA uptake for lower-grade gliomas. J Neurooncol. 2021 May; 152(3):573-582. Tatekawa H, Uetani H, Hagiwara A, Yao J, Yao J, Oughourlian TC, Ueda I, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Bahri S, Pope WB, Salamon N, Ellingson BM. PMID: 33704629; PMCID: PMC8221401.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    98. Differentiating IDH status in human gliomas using machine learning and multiparametric MR/PET. Cancer Imaging. 2021 Mar 10; 21(1):27. Tatekawa H, Hagiwara A, Uetani H, Bahri S, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. PMID: 33691798; PMCID: PMC7944911.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    99. Radiographic read paradigms and the roles of the central imaging laboratory in neuro-oncology clinical trials. Neuro Oncol. 2021 02 25; 23(2):189-198. Ellingson BM, Brown MS, Boxerman JL, Gerstner ER, Kaufmann TJ, Cole PE, Bacha JA, Leung D, Barone A, Colman H, van den Bent MJ, Wen PY, Alfred Yung WK, Cloughesy TF, Goldin JG. PMID: 33130879; PMCID: PMC7906061.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    100. Detection of cerebral reorganization associated with degenerative cervical myelopathy using diffusion spectral imaging (DSI). J Clin Neurosci. 2021 Apr; 86:164-173. Wang C, Holly LT, Oughourlian T, Yao J, Raymond C, Salamon N, Ellingson BM. PMID: 33775321; PMCID: PMC8007933.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    101. A physical phantom for amine chemical exchange saturation transfer (CEST) MRI. MAGMA. 2021 Aug; 34(4):569-580. Yao J, Yao J, Wang C, Raymond C, Bergstrom B, Chen X, Das K, Dinh H, Kim ZS, Le AN, Lim MWJ, Pham JAN, Prusan JD, Rao SS, Nathanson DA, Ellingson BM. PMID: 33484366.
      View in: PubMed   Mentions: 1     Fields:    
    102. Intravoxel incoherent motion (IVIM) modeling of diffusion MRI during chemoradiation predicts therapeutic response in IDH wildtype glioblastoma. Radiother Oncol. 2021 03; 156:258-265. Jabehdar Maralani P, Myrehaug S, Mehrabian H, Chan AKM, Wintermark M, Heyn C, Conklin J, Ellingson BM, Rahimi S, Lau AZ, Tseng CL, Soliman H, Detsky J, Daghighi S, Keith J, Munoz DG, Das S, Atenafu EG, Lipsman N, Perry J, Stanisz G, Sahgal A. PMID: 33418005; PMCID: PMC8186561.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    103. Volumetric analysis of IDH-mutant lower-grade glioma: a natural history study of tumor growth rates before and after treatment. Neuro Oncol. 2020 12 18; 22(12):1822-1830. Huang RY, Young RJ, Ellingson BM, Veeraraghavan H, Wang W, Tixier F, Um H, Nawaz R, Luks T, Kim J, Gerstner ER, Schiff D, Peters KB, Mellinghoff IK, Chang SM, Cloughesy TF, Wen PY. PMID: 32328652; PMCID: PMC7746936.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    104. Minimizing echo and repetition times in magnetic resonance imaging using a double half-echo k-space acquisition and low-rank reconstruction. NMR Biomed. 2021 04; 34(4):e4458. Bydder M, Ali F, Ghodrati V, Hu P, Yao J, Ellingson BM. PMID: 33300182; PMCID: PMC7935763.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    105. Maximum Uptake and Hypermetabolic Volume of 18F-FDOPA PET Estimate Molecular Status and Overall Survival in Low-Grade Gliomas: A PET and MRI Study. Clin Nucl Med. 2020 Dec; 45(12):e505-e511. Tatekawa H, Yao J, Oughourlian TC, Hagiwara A, Wang C, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Salamon N, Ellingson BM. PMID: 33031233; PMCID: PMC7950323.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    106. Novel tonometer device distinguishes brain stiffness in epilepsy surgery. Sci Rep. 2020 12 01; 10(1):20978. Fallah A, Subramaniam T, Phillips HW, Michalet X, Vinters HV, Yong WH, Wu JY, Salamon N, Ellingson BM, Wang AC, Reyes SD, Ibrahim GM, Weil AG, Chang JW, Babayan D, Nguyen JC, Behnke E, Tseng CH, Mathern GW. PMID: 33262385; PMCID: PMC7708453.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    107. Response to Letter to Editor. Neuro Oncol. 2020 11 26; 22(11):1706-1707. Kaufmann TJ, Smits M, Boxerman J, Huang R, Barboriak DP, Weller M, Chung C, Tsien C, Brown PD, Shankar L, Galanis E, Gerstner E, van den Bent MJ, Burns TC, Parney IF, Dunn G, Brastianos PK, Lin NU, Wen PY, Ellingson BM. PMID: 32823280; PMCID: PMC7690353.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    108. Multiparametric MRI for early identification of therapeutic response in recurrent glioblastoma treated with immune checkpoint inhibitors. Neuro Oncol. 2020 11 26; 22(11):1658-1666. Song J, Kadaba P, Kravitz A, Hormigo A, Friedman J, Belani P, Hadjipanayis C, Ellingson BM, Nael K. PMID: 32193547; PMCID: PMC7846197.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    109. Relative oxygen extraction fraction (rOEF) MR imaging reveals higher hypoxia in human epidermal growth factor receptor (EGFR) amplified compared with non-amplified gliomas. Neuroradiology. 2021 Jun; 63(6):857-868. Oughourlian TC, Yao J, Yao J, Hagiwara A, Nathanson DA, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 33106922; PMCID: PMC8071834.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    110. Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor Burden. Neurosurgery. 2020 10 15; 87(5):931-938. Patel KS, Everson RG, Yao J, Yao J, Raymond C, Goldman J, Schlossman J, Tsung J, Tan C, Pope WB, Ji MS, Nguyen NT, Lai A, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 32365185; PMCID: PMC7566341.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    111. Baseline requirements for novel agents being considered for phase II/III brain cancer efficacy trials: conclusions from the Adult Brain Tumor Consortium's first workshop on CNS drug delivery. Neuro Oncol. 2020 10 14; 22(10):1422-1424. Grossman SA, Romo CG, Rudek MA, Supko J, Fisher J, Nabors LB, Wen PY, Peereboom DM, Ellingson BM, Elmquist W, Barker FG, Kamson D, Sarkaria JN, Timmer W, Bindra RS, Ye X. PMID: 32506123; PMCID: PMC7566550.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    112. Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas. Neuro Oncol. 2020 09 29; 22(9):1262-1275. Boxerman JL, Quarles CC, Hu LS, Erickson BJ, Gerstner ER, Smits M, Kaufmann TJ, Barboriak DP, Huang RH, Wick W, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Chung C, van den Bent MJ, Chang S, Al Yung WK, Cloughesy TF, Wen PY, Gilbert MR, Rosen BR, Ellingson BM, Schmainda KM, Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering Committee. PMID: 32516388; PMCID: PMC7523451.
      View in: PubMed   Mentions: 86     Fields:    Translation:Humans
    113. Compensatory brainstem functional and structural connectivity in patients with degenerative cervical myelopathy by probabilistic tractography and functional MRI. Brain Res. 2020 12 15; 1749:147129. Wang C, Laiwalla A, Salamon N, Ellingson BM, Holly LT. PMID: 32950486; PMCID: PMC7606789.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    114. Influence of phosphate concentration on amine, amide, and hydroxyl CEST contrast. Magn Reson Med. 2021 02; 85(2):1062-1078. Yao J, Yao J, Wang C, Ellingson BM. PMID: 32936483; PMCID: PMC8258865.
      View in: PubMed   Mentions: 2     Fields:    
    115. Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naïve diffuse gliomas. J Neurooncol. 2020 Sep; 149(2):337-346. Tatekawa H, Hagiwara A, Uetani H, Yao J, Yao J, Oughourlian TC, Bahri S, Wang C, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. PMID: 32929644; PMCID: PMC7682113.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    116. Decorin expression is associated with predictive diffusion MR phenotypes of anti-VEGF efficacy in glioblastoma. Sci Rep. 2020 09 09; 10(1):14819. Patel KS, Yao J, Yao J, Raymond C, Yong W, Everson R, Liau LM, Nathanson D, Kornblum H, Wang C, Oughourlian T, Lai A, Nghiemphu PL, Pope WB, Cloughesy TF, Ellingson BM. PMID: 32908231; PMCID: PMC7481206.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    117. Focal cortical dysplasia imaging discrepancies between MRI and FDG-PET: Unique association with temporal lobe location. Seizure. 2020 Oct; 81:180-185. Yokota H, Uetani H, Tatekawa H, Hagiwara A, Morimoto E, Linetsky M, Yoo B, Ellingson BM, Salamon N. PMID: 32847766; PMCID: PMC8216482.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    118. Pathophysiology, classification, and MRI parallels in microvascular disease of the heart and brain. Microcirculation. 2020 11; 27(8):e12648. Thomas MA, Hazany S, Ellingson BM, Hu P, Nguyen KL. PMID: 32640064; PMCID: PMC7680357.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    119. Human IDH mutant 1p/19q co-deleted gliomas have low tumor acidity as evidenced by molecular MRI and PET: a retrospective study. Sci Rep. 2020 07 17; 10(1):11922. Yao J, Yao J, Hagiwara A, Raymond C, Shabani S, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 32681084; PMCID: PMC7367867.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    120. Voxelwise and Patientwise Correlation of 18F-FDOPA PET, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient in Treatment-Naïve Diffuse Gliomas with Different Molecular Subtypes. J Nucl Med. 2021 03; 62(3):319-325. Tatekawa H, Hagiwara A, Yao J, Yao J, Oughourlian TC, Ueda I, Uetani H, Raymond C, Lai A, Cloughesy TF, Nghiemphu PL, Liau LM, Pope WB, Salamon N, Ellingson BM. PMID: 32646876; PMCID: PMC8049346.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    121. Ivosidenib in Isocitrate Dehydrogenase 1-Mutated Advanced Glioma. J Clin Oncol. 2020 10 10; 38(29):3398-3406. Mellinghoff IK, Ellingson BM, Touat M, Maher E, De La Fuente MI, Holdhoff M, Cote GM, Burris H, Janku F, Young RJ, Huang R, Jiang L, Choe S, Fan B, Yen K, Lu M, Bowden C, Steelman L, Pandya SS, Cloughesy TF, Wen PY. PMID: 32530764; PMCID: PMC7527160.
      View in: PubMed   Mentions: 127     Fields:    Translation:HumansCTClinical Trials
    122. Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastases. Neuro Oncol. 2020 06 09; 22(6):757-772. Kaufmann TJ, Smits M, Boxerman J, Huang R, Barboriak DP, Weller M, Chung C, Tsien C, Brown PD, Shankar L, Galanis E, Gerstner E, van den Bent MJ, Burns TC, Parney IF, Dunn G, Brastianos PK, Lin NU, Wen PY, Ellingson BM. PMID: 32048719; PMCID: PMC7283031.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    123. Association between cortical volume and gray-white matter contrast with second generation antipsychotic medication exposure in first episode male schizophrenia patients. Schizophr Res. 2020 08; 222:397-410. Chwa WJ, Tishler TA, Raymond C, Tran C, Anwar F, Villablanca JP, Ventura J, Subotnik KL, Nuechterlein KH, Ellingson BM. PMID: 32487466; PMCID: PMC7572538.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    124. A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE). Neuro Oncol. 2020 05 15; 22(5):705-717. Cloughesy TF, Brenner A, de Groot JF, Butowski NA, Zach L, Campian JL, Ellingson BM, Freedman LS, Cohen YC, Lowenton-Spier N, Rachmilewitz Minei T, Fain Shmueli S, GLOBE Study Investigators, Wen PY. PMID: 31844890; PMCID: PMC7229248.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCTClinical Trials
    125. Safety and efficacy of VB-111, an anticancer gene therapy, in patients with recurrent glioblastoma: results of a phase I/II study. Neuro Oncol. 2020 05 15; 22(5):694-704. Brenner AJ, Peters KB, Vredenburgh J, Bokstein F, Blumenthal DT, Yust-Katz S, Peretz I, Oberman B, Freedman LS, Ellingson BM, Cloughesy TF, Sher N, Cohen YC, Lowenton-Spier N, Rachmilewitz Minei T, Yakov N, Mendel I, Breitbart E, Wen PY. PMID: 31844886; PMCID: PMC7229257.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCTClinical Trials
    126. Multiparametric MR-PET Imaging Predicts Pharmacokinetics and Clinical Response to GDC-0084 in Patients with Recurrent High-Grade Glioma. Clin Cancer Res. 2020 07 01; 26(13):3135-3144. Ellingson BM, Yao J, Yao J, Raymond C, Nathanson DA, Chakhoyan A, Simpson J, Garner JS, Olivero AG, Mueller LU, Rodon J, Gerstner E, Cloughesy TF, Wen PY. PMID: 32269051; PMCID: PMC8204664.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    127. Diffusion MRI changes in the anterior subventricular zone following chemoradiation in glioblastoma with posterior ventricular involvement. J Neurooncol. 2020 May; 147(3):643-652. Cho N, Wang C, Raymond C, Kaprealian T, Ji M, Salamon N, Pope WB, Nghiemphu PL, Lai A, Cloughesy TF, Ellingson BM. PMID: 32239430; PMCID: PMC7769136.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    128. Rate of change in maximum 18F-FDOPA PET uptake and non-enhancing tumor volume predict malignant transformation and overall survival in low-grade gliomas. J Neurooncol. 2020 Mar; 147(1):135-145. Oughourlian TC, Yao J, Yao J, Schlossman J, Raymond C, Ji M, Tatekawa H, Salamon N, Pope WB, Czernin J, Nghiemphu PL, Lai A, Cloughesy TF, Ellingson BM. PMID: 31981013; PMCID: PMC7080591.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    129. First-in-Human Phase I Study to Evaluate the Brain-Penetrant PI3K/mTOR Inhibitor GDC-0084 in Patients with Progressive or Recurrent High-Grade Glioma. Clin Cancer Res. 2020 04 15; 26(8):1820-1828. Wen PY, Cloughesy TF, Olivero AG, Morrissey KM, Wilson TR, Lu X, Mueller LU, Coimbra AF, Ellingson BM, Gerstner E, Lee EQ, Rodon J. PMID: 31937616.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCTClinical Trials
    130. On the promise of artificial intelligence for standardizing radiographic response assessment in gliomas. Neuro Oncol. 2019 11 04; 21(11):1346-1347. Ellingson BM. PMID: 31504809; PMCID: PMC6827830.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    131. Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI. Neuro Oncol. 2019 09 06; 21(9):1184-1196. Yao J, Yao J, Chakhoyan A, Nathanson DA, Yong WH, Salamon N, Raymond C, Mareninov S, Lai A, Nghiemphu PL, Prins RM, Pope WB, Everson RG, Liau LM, Cloughesy TF, Ellingson BM. PMID: 31066901; PMCID: PMC7594567.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    132. Neck disability in patients with cervical spondylosis is associated with altered brain functional connectivity. J Clin Neurosci. 2019 Nov; 69:149-154. Holly LT, Wang C, Woodworth DC, Salamon N, Ellingson BM. PMID: 31420276; PMCID: PMC6829058.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    133. Patterns of long-term survivorship following bevacizumab treatment for recurrent glioma: a case series. CNS Oncol. 2019 06 01; 8(2):CNS35. Liu LY, Ji MS, Nguyen NT, Chow FE, Molaie DM, Pianka ST, Green RM, Liau LM, Ellingson BM, Nghiemphu PL, Cloughesy TF, Lai A. PMID: 31293169; PMCID: PMC6713025.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    134. Association between Tumor Acidity and Hypervascularity in Human Gliomas Using pH-Weighted Amine Chemical Exchange Saturation Transfer Echo-Planar Imaging and Dynamic Susceptibility Contrast Perfusion MRI at 3T. AJNR Am J Neuroradiol. 2019 06; 40(6):979-986. Wang YL, Yao J, Chakhoyan A, Raymond C, Salamon N, Liau LM, Nghiemphu PL, Lai A, Pope WB, Nguyen N, Ji M, Cloughesy TF, Ellingson BM. PMID: 31097430; PMCID: PMC6527337.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    135. Spinal Cord Perfusion MR Imaging Implicates Both Ischemia and Hypoxia in the Pathogenesis of Cervical Spondylosis. World Neurosurg. 2019 Aug; 128:e773-e781. Ellingson BM, Woodworth DC, Leu K, Salamon N, Holly LT. PMID: 31077900; PMCID: PMC8805085.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    136. Probabilistic independent component analysis of dynamic susceptibility contrast perfusion MRI in metastatic brain tumors. Cancer Imaging. 2019 Mar 18; 19(1):14. Chakhoyan A, Raymond C, Chen J, Goldman J, Yao J, Yao J, Kaprealian TB, Pouratian N, Ellingson BM. PMID: 30885275; PMCID: PMC6423873.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    137. Alterations in Cortical Thickness and Subcortical Volume are Associated With Neurological Symptoms and Neck Pain in Patients With Cervical Spondylosis. Neurosurgery. 2019 03 01; 84(3):588-598. Woodworth DC, Holly LT, Mayer EA, Salamon N, Ellingson BM. PMID: 29548020; PMCID: PMC6500881.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    138. Urologic chronic pelvic pain syndrome: insights from the MAPP Research Network. Nat Rev Urol. 2019 03; 16(3):187-200. Clemens JQ, Mullins C, Ackerman AL, Bavendam T, van Bokhoven A, Ellingson BM, Harte SE, Kutch JJ, Lai HH, Martucci KT, Moldwin R, Naliboff BD, Pontari MA, Sutcliffe S, Landis JR, MAPP Research Network Study Group. PMID: 30560936; PMCID: PMC6800057.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    139. Validation of vessel size imaging (VSI) in high-grade human gliomas using magnetic resonance imaging, image-guided biopsies, and quantitative immunohistochemistry. Sci Rep. 2019 02 26; 9(1):2846. Chakhoyan A, Yao J, Yao J, Leu K, Pope WB, Salamon N, Yong W, Lai A, Nghiemphu PL, Everson RG, Prins RM, Liau LM, Nathanson DA, Cloughesy TF, Ellingson BM. PMID: 30808879; PMCID: PMC6391482.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    140. pH-weighted amine chemical exchange saturation transfer echoplanar imaging (CEST-EPI) as a potential early biomarker for bevacizumab failure in recurrent glioblastoma. J Neurooncol. 2019 May; 142(3):587-595. Yao J, Yao J, Tan CHP, Schlossman J, Chakhoyan A, Raymond C, Pope WB, Salamon N, Lai A, Ji M, Nghiemphu PL, Liau LM, Cloughesy TF, Ellingson BM. PMID: 30806888; PMCID: PMC6482078.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    141. pH-weighted molecular MRI in human traumatic brain injury (TBI) using amine proton chemical exchange saturation transfer echoplanar imaging (CEST EPI). Neuroimage Clin. 2019; 22:101736. Ellingson BM, Yao J, Yao J, Raymond C, Chakhoyan A, Khatibi K, Salamon N, Villablanca JP, Wanner I, Real CR, Laiwalla A, McArthur DL, Monti MM, Hovda DA, Vespa PM. PMID: 30826686; PMCID: PMC6396390.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    142. Advanced Imaging in the Evaluation of Migraine Headaches. Neuroimaging Clin N Am. 2019 May; 29(2):301-324. Ellingson BM, Hesterman C, Johnston M, Dudeck NR, Charles AC, Villablanca JP. PMID: 30926119; PMCID: PMC8765285.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    143. Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma. Nat Med. 2019 03; 25(3):477-486. Cloughesy TF, Mochizuki AY, Orpilla JR, Hugo W, Lee AH, Davidson TB, Wang AC, Ellingson BM, Rytlewski JA, Sanders CM, Kawaguchi ES, Du L, Li G, Yong WH, Gaffey SC, Cohen AL, Mellinghoff IK, Lee EQ, Reardon DA, O'Brien BJ, Butowski NA, Nghiemphu PL, Clarke JL, Arrillaga-Romany IC, Colman H, Kaley TJ, de Groot JF, Liau LM, Wen PY, Prins RM. PMID: 30742122; PMCID: PMC6408961.
      View in: PubMed   Mentions: 674     Fields:    Translation:HumansCells
    144. Selective middle cerebral artery occlusion in the rabbit: Technique and characterization with pathologic findings and multimodal MRI. J Neurosci Methods. 2019 02 01; 313:6-12. Jahan R, Villablanca JP, Harris RJ, Duarte-Vogel S, Williams CK, Vinters HV, Rao N, Enzmann DR, Ellingson BM. PMID: 30529458.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    145. Changes in brain white matter structure are associated with urine proteins in urologic chronic pelvic pain syndrome (UCPPS): A MAPP Network study. PLoS One. 2018; 13(12):e0206807. Woodworth DC, Dagher A, Curatolo A, Sachdev M, Ashe-McNalley C, Naliboff BD, Labus JS, Landis JR, Kutch JJ, Mayer EA, Lee RS, Moses MA, Ellingson BM, MAPP Research Network. PMID: 30517112; PMCID: PMC6281196.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    146. Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo. Neuro Oncol. 2018 10 09; 20(11):1525-1535. Ellingson BM, Abrey LE, Garcia J, Chinot O, Wick W, Saran F, Nishikawa R, Henriksson R, Mason WP, Harris RJ, Leu K, Woodworth DC, Mehta A, Raymond C, Chakhoyan A, Pope WB, Cloughesy TF. PMID: 29897562; PMCID: PMC6178278.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCTClinical Trials
    147. Longitudinal Patterns in Clinical and Imaging Measurements Predict Residual Survival in Glioblastoma Patients. Sci Rep. 2018 09 26; 8(1):14429. Smedley NF, Ellingson BM, Cloughesy TF, Hsu W. PMID: 30258190; PMCID: PMC6158293.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    148. Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burden. Neurooncol Pract. 2019 Mar; 6(2):103-111. Nguyen HT, Nguyen N, Liu LY, Dovek L, Lenchner D, Harris R, Ozer B, Ravelo A, Sommer N, Sim MS, Elashoff R, Green R, Nghiemphu PL, Cloughesy TF, Ellingson B, Lai A. PMID: 31386050; PMCID: PMC6656330.
      View in: PubMed   Mentions: 3  
    149. Volumetric response quantified using T1 subtraction predicts long-term survival benefit from cabozantinib monotherapy in recurrent glioblastoma. Neuro Oncol. 2018 09 03; 20(10):1411-1418. Ellingson BM, Aftab DT, Schwab GM, Hessel C, Harris RJ, Woodworth DC, Leu K, Chakhoyan A, Raymond C, Drappatz J, de Groot J, Prados MD, Reardon DA, Schiff D, Chamberlain M, Mikkelsen T, Desjardins A, Holland J, Ping J, Weitzman R, Wen PY, Cloughesy TF. PMID: 29660005; PMCID: PMC6120362.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    150. Improving B0 Correction for pH-Weighted Amine Proton Chemical Exchange Saturation Transfer (CEST) Imaging by Use of k-Means Clustering and Lorentzian Estimation. Tomography. 2018 Sep; 4(3):123-137. Yao J, Yao J, Ruan D, Raymond C, Liau LM, Salamon N, Pope WB, Nghiemphu PL, Lai A, Cloughesy TF, Ellingson BM. PMID: 30320212; PMCID: PMC6173788.
      View in: PubMed   Mentions: 15     Fields:    
    151. Resting-State Functional Magnetic Resonance Imaging Connectivity of the Brain Is Associated with Altered Sensorimotor Function in Patients with Cervical Spondylosis. World Neurosurg. 2018 Nov; 119:e740-e749. Woodworth DC, Holly LT, Salamon N, Ellingson BM. PMID: 30092474; PMCID: PMC6200587.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    152. Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma. Neuro Oncol. 2018 08 02; 20(9):1240-1250. Ellingson BM, Abrey LE, Nelson SJ, Kaufmann TJ, Garcia J, Chinot O, Saran F, Nishikawa R, Henriksson R, Mason WP, Wick W, Butowski N, Ligon KL, Gerstner ER, Colman H, de Groot J, Chang S, Mellinghoff I, Young RJ, Alexander BM, Colen R, Taylor JW, Arrillaga-Romany I, Mehta A, Huang RY, Pope WB, Reardon D, Batchelor T, Prados M, Galanis E, Wen PY, Cloughesy TF. PMID: 29660006; PMCID: PMC6071654.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    153. The epilepsy bioinformatics study for anti-epileptogenic therapy (EpiBioS4Rx) clinical biomarker: Study design and protocol. Neurobiol Dis. 2019 03; 123:110-114. Vespa PM, Shrestha V, Abend N, Agoston D, Au A, Bell MJ, Bleck TP, Blanco MB, Claassen J, Diaz-Arrastia R, Duncan D, Ellingson B, Foreman B, Gilmore EJ, Hirsch L, Hunn M, Kamnaksh A, McArthur D, Morokoff A, O'Brien T, O'Phelan K, Robertson CL, Rosenthal E, Staba R, Toga A, Willyerd FA, Zimmermann L, Yam E, Martinez S, Real C, Engel J. PMID: 30048805; PMCID: PMC6344322.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    154. ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy. PLoS One. 2018; 13(6):e0198548. Ratai EM, Zhang Z, Fink J, Muzi M, Hanna L, Greco E, Richards T, Kim D, Andronesi OC, Mintz A, Kostakoglu L, Prah M, Ellingson B, Schmainda K, Sorensen G, Barboriak D, Mankoff D, Gerstner ER, ACRIN 6684 trial group. PMID: 29902200; PMCID: PMC6002091.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCTClinical Trials
    155. Early seizures and temporal lobe trauma predict post-traumatic epilepsy: A longitudinal study. Neurobiol Dis. 2019 03; 123:115-121. Tubi MA, Lutkenhoff E, Blanco MB, McArthur D, Villablanca P, Ellingson B, Diaz-Arrastia R, Van Ness P, Real C, Shrestha V, Engel J, Vespa PM. PMID: 29859872; PMCID: PMC6274611.
      View in: PubMed   Mentions: 52     Fields:    Translation:Humans
    156. Mono-exponential, diffusion kurtosis and stretched exponential diffusion MR imaging response to chemoradiation in newly diagnosed glioblastoma. J Neurooncol. 2018 Sep; 139(3):651-659. Chakhoyan A, Woodworth DC, Harris RJ, Lai A, Nghiemphu PL, Liau LM, Pope WB, Cloughesy TF, Ellingson BM. PMID: 29855771; PMCID: PMC6126989.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    157. 18F-FDOPA PET and MRI characteristics correlate with degree of malignancy and predict survival in treatment-naïve gliomas: a cross-sectional study. J Neurooncol. 2018 Sep; 139(2):399-409. Patel CB, Fazzari E, Chakhoyan A, Yao J, Yao J, Raymond C, Nguyen H, Manoukian J, Nguyen N, Pope W, Cloughesy TF, Nghiemphu PL, Czernin J, Lai A, Ellingson BM. PMID: 29679199; PMCID: PMC6092195.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    158. Understanding brain penetrance of anticancer drugs. Neuro Oncol. 2018 04 09; 20(5):589-596. Levin VA, Ellingson BM. PMID: 29474640; PMCID: PMC5892153.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimals
    159. Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi-echo amine proton chemical exchange saturation transfer spin-and-gradient echo echo-planar imaging (CEST-SAGE-EPI). Magn Reson Med. 2018 11; 80(5):1962-1978. Harris RJ, Yao J, Yao J, Chakhoyan A, Raymond C, Leu K, Liau LM, Nghiemphu PL, Lai A, Salamon N, Pope WB, Cloughesy TF, Ellingson BM. PMID: 29626359; PMCID: PMC6107417.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    160. Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglio. Neuro Oncol. 2018 03 27; 20(4):557-566. Nowosielski M, Ellingson BM, Chinot OL, Garcia J, Revil C, Radbruch A, Nishikawa R, Mason WP, Henriksson R, Saran F, Kickingereder P, Platten M, Sandmann T, Abrey LE, Cloughesy TF, Bendszus M, Wick W. PMID: 29016943; PMCID: PMC5909665.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCellsCTClinical Trials
    161. Evidence and context of use for contrast enhancement as a surrogate of disease burden and treatment response in malignant glioma. Neuro Oncol. 2018 03 27; 20(4):457-471. Ellingson BM, Wen PY, Cloughesy TF. PMID: 29040703; PMCID: PMC5909663.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    162. Reproducibility, temporal stability, and functional correlation of diffusion MR measurements within the spinal cord in patients with asymptomatic cervical stenosis or cervical myelopathy. J Neurosurg Spine. 2018 05; 28(5):472-480. Ellingson BM, Salamon N, Woodworth DC, Yokota H, Holly LT. PMID: 29424671; PMCID: PMC5930078.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    163. Disease-Related Microstructural Differences in the Brain in Women With Provoked Vestibulodynia. J Pain. 2018 05; 19(5):528.e1-528.e15. Gupta A, Woodworth DC, Ellingson BM, Rapkin AJ, Naliboff B, Kilpatrick LA, Stains J, Masghati S, Tillisch K, Mayer EA, Labus JS. PMID: 29391213; PMCID: PMC5927835.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    164. Gadolinium deposition in the paediatric brain: T1-weighted hyperintensity within the dentate nucleus following repeated gadolinium-based contrast agent administration. Clin Radiol. 2018 03; 73(3):290-295. Young JR, Orosz I, Franke MA, Kim HJ, Woodworth D, Ellingson BM, Salamon N, Pope WB. PMID: 29208312.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    165. Improved Spatiotemporal Resolution of Dynamic Susceptibility Contrast Perfusion MRI in Brain Tumors Using Simultaneous Multi-Slice Echo-Planar Imaging. AJNR Am J Neuroradiol. 2018 01; 39(1):43-45. Chakhoyan A, Leu K, Pope WB, Cloughesy TF, Ellingson BM. PMID: 29074632; PMCID: PMC5766430.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    166. Application of arterial spin labeling perfusion MRI to differentiate benign from malignant intracranial meningiomas. Eur J Radiol. 2017 Dec; 97:31-36. Qiao XJ, Kim HG, Wang DJJ, Salamon N, Linetsky M, Sepahdari A, Ellingson BM, Pope WB. PMID: 29153364; PMCID: PMC6165628.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    167. Detection of immune responses after immunotherapy in glioblastoma using PET and MRI. Proc Natl Acad Sci U S A. 2017 09 19; 114(38):10220-10225. Antonios JP, Soto H, Everson RG, Moughon DL, Wang AC, Orpilla J, Radu C, Ellingson BM, Lee JT, Cloughesy T, Phelps ME, Czernin J, Liau LM, Prins RM. PMID: 28874539; PMCID: PMC5617282.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansAnimalsCells
    168. Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials. Clin Cancer Res. 2017 Oct 01; 23(19):5745-5756. Ellingson BM, Gerstner ER, Smits M, Huang RY, Colen R, Abrey LE, Aftab DT, Schwab GM, Hessel C, Harris RJ, Chakhoyan A, Gahrmann R, Pope WB, Leu K, Raymond C, Woodworth DC, de Groot J, Wen PY, Batchelor TT, van den Bent MJ, Cloughesy TF. PMID: 28655794; PMCID: PMC5626594.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCTClinical Trials
    169. Longitudinal DSC-MRI for Distinguishing Tumor Recurrence From Pseudoprogression in Patients With a High-grade Glioma. Am J Clin Oncol. 2017 Jun; 40(3):228-234. Boxerman JL, Ellingson BM, Jeyapalan S, Elinzano H, Harris RJ, Rogg JM, Pope WB, Safran H. PMID: 25436828.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    170. Metabolic Imaging Using Proton Magnetic Spectroscopy as a Predictor of Outcome After Surgery for Cervical Spondylotic Myelopathy. Clin Spine Surg. 2017 Jun; 30(5):E615-E619. Holly LT, Ellingson BM, Salamon N. PMID: 28525487; PMCID: PMC4510035.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    171. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas. J Neurooncol. 2017 Aug; 134(1):177-188. Leu K, Ott GA, Lai A, Nghiemphu PL, Pope WB, Yong WH, Liau LM, Cloughesy TF, Ellingson BM. PMID: 28547590; PMCID: PMC7927357.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    172. Pseudoprogression, radionecrosis, inflammation or true tumor progression? challenges associated with glioblastoma response assessment in an evolving therapeutic landscape. J Neurooncol. 2017 Sep; 134(3):495-504. Ellingson BM, Chung C, Pope WB, Boxerman JL, Kaufmann TJ. PMID: 28382534; PMCID: PMC7893814.
      View in: PubMed   Mentions: 114     Fields:    Translation:HumansPHPublic Health
    173. Modified Criteria for Radiographic Response Assessment in Glioblastoma Clinical Trials. Neurotherapeutics. 2017 04; 14(2):307-320. Ellingson BM, Wen PY, Cloughesy TF. PMID: 28108885; PMCID: PMC5398984.
      View in: PubMed   Mentions: 209     Fields:    Translation:Humans
    174. Abnormal Trajectory of Intracortical Myelination in Schizophrenia Implicates White Matter in Disease Pathophysiology and the Therapeutic Mechanism of Action of Antipsychotics. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 05; 3(5):454-462. Tishler TA, Bartzokis G, Lu PH, Raven EP, Khanoyan M, Kirkpatrick CJ, Pyle MH, Villablanca JP, Altshuler LL, Mintz J, Ventura J, Casaus LR, Subotnik KL, Nuechterlein KH, Ellingson BM. PMID: 29735155.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    175. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy. Neuro Oncol. 2017 03 01; 19(3):394-404. Nguyen HN, Lie A, Li T, Chowdhury R, Liu F, Ozer B, Wei B, Green RM, Ellingson BM, Wang HJ, Elashoff R, Liau LM, Yong WH, Nghiemphu PL, Cloughesy T, Lai A. PMID: 27571882; PMCID: PMC5464302.
      View in: PubMed   Mentions: 57     Fields:    Translation:HumansCells
    176. Evaluation of Encephaloduroarteriosynangiosis Efficacy Using Probabilistic Independent Component Analysis Applied to Dynamic Susceptibility Contrast Perfusion MRI. AJNR Am J Neuroradiol. 2017 Mar; 38(3):507-514. Laiwalla AN, Kurth F, Leu K, Liou R, Pamplona J, Ooi YC, Salamon N, Ellingson BM, Gonzalez NR. PMID: 28104642; PMCID: PMC5832053.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    177. Effects of MRI Protocol Parameters, Preload Injection Dose, Fractionation Strategies, and Leakage Correction Algorithms on the Fidelity of Dynamic-Susceptibility Contrast MRI Estimates of Relative Cerebral Blood Volume in Gliomas. AJNR Am J Neuroradiol. 2017 Mar; 38(3):478-484. Leu K, Boxerman JL, Ellingson BM. PMID: 28034995; PMCID: PMC7959993.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    178. Brain white matter changes associated with urological chronic pelvic pain syndrome: multisite neuroimaging from a MAPP case-control study. Pain. 2016 12; 157(12):2782-2791. Huang L, Kutch JJ, Ellingson BM, Martucci KT, Harris RE, Clauw DJ, Mackey S, Mayer EA, Schaeffer AJ, Apkarian AV, Farmer MA, MAPP Research Network. PMID: 27842046; PMCID: PMC5117992.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    179. Simulation, phantom validation, and clinical evaluation of fast pH-weighted molecular imaging using amine chemical exchange saturation transfer echo planar imaging (CEST-EPI) in glioma at 3 T. NMR Biomed. 2016 11; 29(11):1563-1576. Harris RJ, Cloughesy TF, Liau LM, Nghiemphu PL, Lai A, Pope WB, Ellingson BM. PMID: 27717216.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    180. Dynamic Susceptibility Contrast MR Imaging in Glioma: Review of Current Clinical Practice. Magn Reson Imaging Clin N Am. 2016 Nov; 24(4):649-670. Boxerman JL, Shiroishi MS, Ellingson BM, Pope WB. PMID: 27742108.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    181. Baseline pretreatment contrast enhancing tumor volume including central necrosis is a prognostic factor in recurrent glioblastoma: evidence from single and multicenter trials. Neuro Oncol. 2017 01; 19(1):89-98. Ellingson BM, Harris RJ, Woodworth DC, Leu K, Zaw O, Mason WP, Sahebjam S, Abrey LE, Aftab DT, Schwab GM, Hessel C, Lai A, Nghiemphu PL, Pope WB, Wen PY, Cloughesy TF. PMID: 27580889; PMCID: PMC5193027.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansCTClinical Trials
    182. Modeling the efficacy of the extent of surgical resection in the setting of radiation therapy for glioblastoma. Cancer Sci. 2016 Aug; 107(8):1110-6. Hathout L, Ellingson B, Pope W. PMID: 27240229; PMCID: PMC4982585.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    183. Traumatic hemorrhagic brain injury: impact of location and resorption on cognitive outcome. J Neurosurg. 2017 Mar; 126(3):796-804. Martin RM, Wright MJ, Lutkenhoff ES, Ellingson BM, Van Horn JD, Tubi M, Alger JR, McArthur DL, Vespa PM. PMID: 27231979.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    184. ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI. Clin Cancer Res. 2016 Oct 15; 22(20):5079-5086. Gerstner ER, Zhang Z, Fink JR, Muzi M, Hanna L, Greco E, Prah M, Schmainda KM, Mintz A, Kostakoglu L, Eikman EA, Ellingson BM, Ratai EM, Sorensen AG, Barboriak DP, Mankoff DA, ACRIN 6684 Trial Group. PMID: 27185374; PMCID: PMC5065740.
      View in: PubMed   Mentions: 59     Fields:    Translation:Humans
    185. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol. 2016 09; 18(9):1199-208. Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, la Fougère C, Pope W, Law I, Arbizu J, Chamberlain MC, Vogelbaum M, Ellingson BM, Tonn JC. PMID: 27106405; PMCID: PMC4999003.
      View in: PubMed   Mentions: 335     Fields:    Translation:HumansAnimals
    186. Assessing Variability in Brain Tumor Segmentation to Improve Volumetric Accuracy and Characterization of Change. IEEE EMBS Int Conf Biomed Health Inform. 2016 Feb; 2016:380-383. Rios Piedra EA, Taira RK, El-Saden S, Ellingson BM, Bui AAT, Hsu W. PMID: 28670648; PMCID: PMC5489257.
      View in: PubMed   Mentions: 1  
    187. Improved Leakage Correction for Single-Echo Dynamic Susceptibility Contrast Perfusion MRI Estimates of Relative Cerebral Blood Volume in High-Grade Gliomas by Accounting for Bidirectional Contrast Agent Exchange. AJNR Am J Neuroradiol. 2016 Aug; 37(8):1440-6. Leu K, Boxerman JL, Cloughesy TF, Lai A, Nghiemphu PL, Liau LM, Pope WB, Ellingson BM. PMID: 27079371; PMCID: PMC4983482.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    188. Contrast-enhancing tumor growth dynamics of preoperative, treatment-naive human glioblastoma. Cancer. 2016 06 01; 122(11):1718-27. Ellingson BM, Nguyen HN, Lai A, Nechifor RE, Zaw O, Pope WB, Yong WH, Nghiemphu PL, Liau LM, Cloughesy TF. PMID: 26998740.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    189. Bidirectional Contrast agent leakage correction of dynamic susceptibility contrast (DSC)-MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab. J Magn Reson Imaging. 2016 11; 44(5):1229-1237. Leu K, Boxerman JL, Lai A, Nghiemphu PL, Pope WB, Cloughesy TF, Ellingson BM. PMID: 26971534.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    190. Multisite, multimodal neuroimaging of chronic urological pelvic pain: Methodology of the MAPP Research Network. Neuroimage Clin. 2016; 12:65-77. Alger JR, Ellingson BM, Ashe-McNalley C, Woodworth DC, Labus JS, Farmer M, Huang L, Apkarian AV, Johnson KA, Mackey SC, Ness TJ, Deutsch G, Harris RE, Clauw DJ, Glover GH, Parrish TB, Hollander Jd, Kusek JW, Mullins C, Mayer EA, MAPP Research Network Investigators. PMID: 27408791; PMCID: PMC4925887.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    191. DTI of tuber and perituberal tissue can predict epileptogenicity in tuberous sclerosis complex. Neurology. 2015 Dec 08; 85(23):2011-5. Yogi A, Hirata Y, Karavaeva E, Harris RJ, Wu JY, Yudovin SL, Linetsky M, Mathern GW, Ellingson BM, Salamon N. PMID: 26546629; PMCID: PMC4676752.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    192. Prefrontal and Hippocampal Brain Volume Deficits: Role of Low Physical Activity on Brain Plasticity in First-Episode Schizophrenia Patients. J Int Neuropsychol Soc. 2015 Nov; 21(10):868-79. McEwen SC, Hardy A, Ellingson BM, Jarrahi B, Sandhu N, Subotnik KL, Ventura J, Nuechterlein KH. PMID: 26581798; PMCID: PMC4654705.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    193. Immunotherapy response assessment in neuro-oncology: a report of the RANO working group. Lancet Oncol. 2015 Nov; 16(15):e534-e542. Okada H, Weller M, Huang R, Finocchiaro G, Gilbert MR, Wick W, Ellingson BM, Hashimoto N, Pollack IF, Brandes AA, Franceschi E, Herold-Mende C, Nayak L, Panigrahy A, Pope WB, Prins R, Sampson JH, Wen PY, Reardon DA. PMID: 26545842; PMCID: PMC4638131.
      View in: PubMed   Mentions: 353     Fields:    Translation:Humans
    194. Association between lesion location and language function in adult glioma using voxel-based lesion-symptom mapping. Neuroimage Clin. 2015; 9:617-24. Banerjee P, Leu K, Harris RJ, Cloughesy TF, Lai A, Nghiemphu PL, Pope WB, Bookheimer SY, Ellingson BM. PMID: 26740915; PMCID: PMC4644251.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    195. The Impact of T2/FLAIR Evaluation per RANO Criteria on Response Assessment of Recurrent Glioblastoma Patients Treated with Bevacizumab. Clin Cancer Res. 2016 Feb 01; 22(3):575-81. Huang RY, Rahman R, Ballman KV, Felten SJ, Anderson SK, Ellingson BM, Nayak L, Lee EQ, Abrey LE, Galanis E, Reardon DA, Pope WB, Cloughesy TF, Wen PY. PMID: 26490307.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    196. Topographical Distribution of Epileptogenic Tubers in Patients With Tuberous Sclerosis Complex. J Child Neurol. 2016 Apr; 31(5):636-45. Ellingson BM, Hirata Y, Yogi A, Karavaeva E, Leu K, Woodworth DC, Harris RJ, Enzmann DR, Wu JY, Mathern GW, Salamon N. PMID: 26472749.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    197. Unique Microstructural Changes in the Brain Associated with Urological Chronic Pelvic Pain Syndrome (UCPPS) Revealed by Diffusion Tensor MRI, Super-Resolution Track Density Imaging, and Statistical Parameter Mapping: A MAPP Network Neuroimaging Study. PLoS One. 2015; 10(10):e0140250. Woodworth D, Mayer E, Leu K, Ashe-McNalley C, Naliboff BD, Labus JS, Tillisch K, Kutch JJ, Farmer MA, Apkarian AV, Johnson KA, Mackey SC, Ness TJ, Landis JR, Deutsch G, Harris RE, Clauw DJ, Mullins C, Ellingson BM, MAPP Research Network. PMID: 26460744; PMCID: PMC4604194.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    198. Prediction of Neurological Impairment in Cervical Spondylotic Myelopathy using a Combination of Diffusion MRI and Proton MR Spectroscopy. PLoS One. 2015; 10(10):e0139451. Ellingson BM, Salamon N, Hardy AJ, Holly LT. PMID: 26431174; PMCID: PMC4592013.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCellsCTClinical Trials
    199. The Risk of Acute Spinal Cord Injury After Minor Trauma in Patients With Preexisting Cervical Stenosis. Neurosurgery. 2015 Oct; 77(4):561-5; discussion 565. Chang V, Ellingson BM, Salamon N, Holly LT. PMID: 26191975; PMCID: PMC4575254.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    200. Standardized Brain Tumor Imaging Protocol for Clinical Trials. AJNR Am J Neuroradiol. 2015 Oct; 36(10):E65-6. Goldmacher GV, Ellingson BM, Boxerman J, Barboriak D, Pope WB, Gilbert M. PMID: 26359146; PMCID: PMC7965043.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    201. Impact of Software Modeling on the Accuracy of Perfusion MRI in Glioma. AJNR Am J Neuroradiol. 2015 Dec; 36(12):2242-9. Hu LS, Kelm Z, Korfiatis P, Dueck AC, Elrod C, Ellingson BM, Kaufmann TJ, Eschbacher JM, Karis JP, Smith K, Nakaji P, Brinkman D, Pafundi D, Baxter LC, Erickson BJ. PMID: 26359151; PMCID: PMC4681640.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    202. Parametric Response Mapping of Apparent Diffusion Coefficient as an Imaging Biomarker to Distinguish Pseudoprogression from True Tumor Progression in Peptide-Based Vaccine Therapy for Pediatric Diffuse Intrinsic Pontine Glioma. AJNR Am J Neuroradiol. 2015 Nov; 36(11):2170-6. Ceschin R, Kurland BF, Abberbock SR, Ellingson BM, Okada H, Jakacki RI, Pollack IF, Panigrahy A. PMID: 26338910; PMCID: PMC4644687.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansPHPublic Health
    203. Diffusion MR Characteristics Following Concurrent Radiochemotherapy Predicts Progression-Free and Overall Survival in Newly Diagnosed Glioblastoma. Tomography. 2015 Sep; 1(1):37-43. Chang W, Pope WB, Harris RJ, Hardy AJ, Leu K, Mody RR, Nghiemphu PL, Lai A, Cloughesy TF, Ellingson BM. PMID: 26740971; PMCID: PMC4698970.
      View in: PubMed   Mentions: 8     Fields:    
    204. Ionic charge transport between blockages: Sodium cation conduction in freshly excised bulk brain tissue. AIP Adv. 2015 Aug; 5(8):087133. Emin D, Akhtari M, Ellingson BM, Mathern GW. PMID: 26339528; PMCID: PMC4537479.
      View in: PubMed   Mentions: 3  
    205. Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials. Neuro Oncol. 2015 Sep; 17(9):1188-98. Ellingson BM, Bendszus M, Boxerman J, Barboriak D, Erickson BJ, Smits M, Nelson SJ, Gerstner E, Alexander B, Goldmacher G, Wick W, Vogelbaum M, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Pope WB, Yang D, Chung C, Knopp MV, Cha S, van den Bent MJ, Chang S, Yung WK, Cloughesy TF, Wen PY, Gilbert MR, Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering Committee. PMID: 26250565; PMCID: PMC4588759.
      View in: PubMed   Mentions: 322     Fields:    Translation:Humans
    206. pH-weighted molecular imaging of gliomas using amine chemical exchange saturation transfer MRI. Neuro Oncol. 2015 Nov; 17(11):1514-24. Harris RJ, Cloughesy TF, Liau LM, Prins RM, Antonios JP, Li D, Yong WH, Pope WB, Lai A, Nghiemphu PL, Ellingson BM. PMID: 26113557; PMCID: PMC4648305.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansAnimals
    207. Radial expansion rates and tumor growth kinetics predict malignant transformation in contrast-enhancing low-grade diffuse astrocytoma. CNS Oncol. 2015; 4(4):247-56. Hathout L, Pope WB, Lai A, Nghiemphu PL, Cloughesy TF, Ellingson BM. PMID: 26095141; PMCID: PMC4538925.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    208. Response Assessment and Magnetic Resonance Imaging Issues for Clinical Trials Involving High-Grade Gliomas. Top Magn Reson Imaging. 2015 Jun; 24(3):127-36. Boxerman JL, Ellingson BM. PMID: 26049816.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    209. Novel Magnetic Resonance Imaging Techniques in Brain Tumors. Top Magn Reson Imaging. 2015 Jun; 24(3):137-46. Nechifor RE, Harris RJ, Ellingson BM. PMID: 26049817.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    210. Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas. Mol Imaging Biol. 2015 Jun; 17(3):434-42. Karavaeva E, Harris RJ, Leu K, Shabihkhani M, Yong WH, Pope WB, Lai A, Nghiemphu PL, Liau LM, Chen W, Czernin J, Cloughesy TF, Ellingson BM. PMID: 25465392.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    211. Quantitative multiparametric MRI in uveal melanoma: increased tumor permeability may predict monosomy 3. Neuroradiology. 2015 Aug; 57(8):833-40. Kamrava M, Sepahdari AR, Leu K, Wang PC, Roberts K, Demanes DJ, McCannel T, Ellingson BM. PMID: 26022354.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    212. Patient-specific characterization of the invasiveness and proliferation of low-grade gliomas using serial MR imaging and a mathematical model of tumor growth. Oncol Rep. 2015 Jun; 33(6):2883-8. Hathout L, Ellingson BM, Cloughesy TF, Pope WB. PMID: 25962999.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    213. Quantification of Nonenhancing Tumor Burden in Gliomas Using Effective T2 Maps Derived from Dual-Echo Turbo Spin-Echo MRI. Clin Cancer Res. 2015 Oct 01; 21(19):4373-83. Ellingson BM, Lai A, Nguyen HN, Nghiemphu PL, Pope WB, Cloughesy TF. PMID: 25901082; PMCID: PMC4592379.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    214. Pain and Interoception Imaging Network (PAIN): A multimodal, multisite, brain-imaging repository for chronic somatic and visceral pain disorders. Neuroimage. 2016 Jan 01; 124(Pt B):1232-1237. Labus JS, Naliboff B, Kilpatrick L, Liu C, Ashe-McNalley C, Dos Santos IR, Alaverdyan M, Woodworth D, Gupta A, Ellingson BM, Tillisch K, Mayer EA. PMID: 25902408; PMCID: PMC4627849.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    215. MRI perfusion measurements calculated using advanced deconvolution techniques predict survival in recurrent glioblastoma treated with bevacizumab. J Neurooncol. 2015 May; 122(3):497-505. Harris RJ, Cloughesy TF, Hardy AJ, Liau LM, Pope WB, Nghiemphu PL, Lai A, Ellingson BM. PMID: 25773062.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    216. Correlation between degree of subvoxel spinal cord compression measured with super-resolution tract density imaging and neurological impairment in cervical spondylotic myelopathy. J Neurosurg Spine. 2015 Jun; 22(6):631-8. Ellingson BM, Salamon N, Woodworth DC, Holly LT. PMID: 25746116; PMCID: PMC5565223.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    217. Brain White Matter Abnormalities in Female Interstitial Cystitis/Bladder Pain Syndrome: A MAPP Network Neuroimaging Study. J Urol. 2015 Jul; 194(1):118-26. Farmer MA, Huang L, Martucci K, Yang CC, Maravilla KR, Harris RE, Clauw DJ, Mackey S, Ellingson BM, Mayer EA, Schaeffer AJ, Apkarian AV, MAPP Research Network. PMID: 25711200; PMCID: PMC4475466.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    218. Diffusion MRI quality control and functional diffusion map results in ACRIN 6677/RTOG 0625: a multicenter, randomized, phase II trial of bevacizumab and chemotherapy in recurrent glioblastoma. Int J Oncol. 2015 May; 46(5):1883-92. Ellingson BM, Kim E, Woodworth DC, Marques H, Boxerman JL, Safriel Y, McKinstry RC, Bokstein F, Jain R, Chi TL, Sorensen AG, Gilbert MR, Barboriak DP. PMID: 25672376; PMCID: PMC4383029.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCTClinical Trials
    219. Patterns of brain structural connectivity differentiate normal weight from overweight subjects. Neuroimage Clin. 2015; 7:506-17. Gupta A, Mayer EA, Sanmiguel CP, Van Horn JD, Woodworth D, Ellingson BM, Fling C, Love A, Tillisch K, Labus JS. PMID: 25737959; PMCID: PMC4338207.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    220. Radiogenomics and imaging phenotypes in glioblastoma: novel observations and correlation with molecular characteristics. Curr Neurol Neurosci Rep. 2015 Jan; 15(1):506. Ellingson BM. PMID: 25410316.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansAnimals
    221. Arterial spin-labeling perfusion MRI stratifies progression-free survival and correlates with epidermal growth factor receptor status in glioblastoma. AJNR Am J Neuroradiol. 2015 Apr; 36(4):672-7. Qiao XJ, Ellingson BM, Kim HJ, Wang DJ, Salamon N, Linetsky M, Sepahdari AR, Jiang B, Tian JJ, Esswein SR, Cloughesy TF, Lai A, Nghiemphu L, Pope WB. PMID: 25542879; PMCID: PMC7964328.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    222. Hypervascular tumor volume estimated by comparison to a large-scale cerebral blood volume radiographic atlas predicts survival in recurrent glioblastoma treated with bevacizumab. Cancer Imaging. 2014 Nov 14; 14:31. Leu K, Enzmann DR, Woodworth DC, Harris RJ, Tran AN, Lai A, Nghiemphu PL, Pope WB, Cloughesy TF, Ellingson BM. PMID: 25608485; PMCID: PMC4331836.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    223. A novel bicompartmental mathematical model of glioblastoma multiforme. Int J Oncol. 2015 Feb; 46(2):825-32. Hathout L, Ellingson BM, Cloughesy T, Pope WB. PMID: 25384756.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    224. Impact of imaging measurements on response assessment in glioblastoma clinical trials. Neuro Oncol. 2014 Oct; 16 Suppl 7:vii24-35. Reardon DA, Ballman KV, Buckner JC, Chang SM, Ellingson BM. PMID: 25313236; PMCID: PMC4195531.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    225. Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD). Neuro Oncol. 2014 Oct; 16 Suppl 7:vii36-47. Wen PY, Cloughesy TF, Ellingson BM, Reardon DA, Fine HA, Abrey L, Ballman K, Bendszuz M, Buckner J, Chang SM, Prados MD, Pope WB, Gregory Sorensen A, van den Bent M, Yung WK. PMID: 25313237; PMCID: PMC4195530.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    226. Emerging techniques and technologies in brain tumor imaging. Neuro Oncol. 2014 Oct; 16 Suppl 7:vii12-23. Ellingson BM, Bendszus M, Sorensen AG, Pope WB. PMID: 25313234; PMCID: PMC4195527.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    227. Pros and cons of current brain tumor imaging. Neuro Oncol. 2014 Oct; 16 Suppl 7:vii2-11. Ellingson BM, Wen PY, van den Bent MJ, Cloughesy TF. PMID: 25313235; PMCID: PMC4195528.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    228. Nitroxoline induces apoptosis and slows glioma growth in vivo. Neuro Oncol. 2015 Jan; 17(1):53-62. Lazovic J, Guo L, Nakashima J, Mirsadraei L, Yong W, Kim HJ, Ellingson B, Wu H, Pope WB. PMID: 25074541; PMCID: PMC4483047.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    229. Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy. Clin Cancer Res. 2014 Jul 01; 20(13):3550-9. Schwarzenberg J, Czernin J, Cloughesy TF, Ellingson BM, Pope WB, Grogan T, Elashoff D, Geist C, Silverman DH, Phelps ME, Chen W. PMID: 24687922; PMCID: PMC4079729.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    230. Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy. Neuro Oncol. 2014 Jun; 16(6):815-22. Piccioni DE, Selfridge J, Mody RR, Chowdhury R, Li S, Lalezari S, Wawrzynski J, Quan J, Zurayk M, Chou AP, Sanchez DE, Liau LM, Ellingson BM, Pope WB, Nghiemphu PL, Green RM, Wang HJ, Yong WH, Elashoff R, Cloughesy TF, Lai A. PMID: 24627236; PMCID: PMC4022228.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    231. Diffusion tensor imaging predicts functional impairment in mild-to-moderate cervical spondylotic myelopathy. Spine J. 2014 Nov 01; 14(11):2589-97. Ellingson BM, Salamon N, Grinstead JW, Holly LT. PMID: 24561036; PMCID: PMC4426500.
      View in: PubMed   Mentions: 35     Fields:    Translation:Humans
    232. Short-interval estimation of proliferation rate using serial diffusion MRI predicts progression-free survival in newly diagnosed glioblastoma treated with radiochemotherapy. J Neurooncol. 2014 Feb; 116(3):601-8. Zaw TM, Pope WB, Cloughesy TF, Lai A, Nghiemphu PL, Ellingson BM. PMID: 24395348; PMCID: PMC3955987.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    233. Altered functional connectivity of the default mode network in diffuse gliomas measured with pseudo-resting state fMRI. J Neurooncol. 2014 Jan; 116(2):373-9. Harris RJ, Bookheimer SY, Cloughesy TF, Kim HJ, Pope WB, Lai A, Nghiemphu PL, Liau LM, Ellingson BM. PMID: 24234804; PMCID: PMC6763342.
      View in: PubMed   Mentions: 53     Fields:    Translation:Humans
    234. Nonlinear distortion correction of diffusion MR images improves quantitative DTI measurements in glioblastoma. J Neurooncol. 2014 Feb; 116(3):551-8. Woodworth DC, Pope WB, Liau LM, Kim HJ, Lai A, Nghiemphu PL, Cloughesy TF, Ellingson BM. PMID: 24318915; PMCID: PMC3918907.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    235. Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry. Neuro Oncol. 2014 Mar; 16(3):414-20. Tran AN, Lai A, Li S, Pope WB, Teixeira S, Harris RJ, Woodworth DC, Nghiemphu PL, Cloughesy TF, Ellingson BM. PMID: 24305712; PMCID: PMC3922511.
      View in: PubMed   Mentions: 61     Fields:    Translation:Humans
    236. Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial. Radiology. 2014 Apr; 271(1):200-10. Ellingson BM, Kim HJ, Woodworth DC, Pope WB, Cloughesy JN, Harris RJ, Lai A, Nghiemphu PL, Cloughesy TF. PMID: 24475840; PMCID: PMC4263651.
      View in: PubMed   Mentions: 130     Fields:    Translation:HumansCTClinical Trials
    237. Glioblastoma treatment using perphenazine to block the subventricular zone's tumor trophic functions. J Neurooncol. 2014 Jan; 116(2):207-12. Kast RE, Ellingson BM, Marosi C, Halatsch ME. PMID: 24242756.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    238. Pretreatment ADC histogram analysis is a predictive imaging biomarker for bevacizumab treatment but not chemotherapy in recurrent glioblastoma. AJNR Am J Neuroradiol. 2014 Apr; 35(4):673-9. Ellingson BM, Sahebjam S, Kim HJ, Pope WB, Harris RJ, Woodworth DC, Lai A, Nghiemphu PL, Mason WP, Cloughesy TF. PMID: 24136647; PMCID: PMC7965805.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    239. Advances in MR imaging for cervical spondylotic myelopathy. Eur Spine J. 2015 Apr; 24 Suppl 2:197-208. Ellingson BM, Salamon N, Holly LT. PMID: 23917647; PMCID: PMC4879123.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    240. Peripheral vascular disease as remote ischemic preconditioning, for acute stroke. Clin Neurol Neurosurg. 2013 Oct; 115(10):2124-9. Connolly M, Bilgin-Freiert A, Ellingson B, Dusick JR, Liebeskind D, Saver J, Gonzalez NR. PMID: 23958050; PMCID: PMC3798063.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    241. Perfusion deficits detected by arterial spin-labeling in patients with TIA with negative diffusion and vascular imaging. AJNR Am J Neuroradiol. 2013 Nov-Dec; 34(11):2125-30. Qiao XJ, Salamon N, Wang DJ, He R, Linetsky M, Ellingson BM, Pope WB. PMID: 23721895; PMCID: PMC3864013.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    242. Proton magnetic resonance spectroscopy of human cervical spondylosis at 3T. Spinal Cord. 2013 Jul; 51(7):558-63. Salamon N, Ellingson BM, Nagarajan R, Gebara N, Thomas A, Holly LT. PMID: 23588574; PMCID: PMC3703492.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    243. Diffusion tensor imaging detects microstructural reorganization in the brain associated with chronic irritable bowel syndrome. Pain. 2013 Sep; 154(9):1528-1541. Ellingson BM, Mayer E, Harris RJ, Ashe-McNally C, Naliboff BD, Labus JS, Tillisch K. PMID: 23721972; PMCID: PMC3758125.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    244. Dyspepsia: Structural changes in functional gastrointestinal disorders. Nat Rev Gastroenterol Hepatol. 2013 Apr; 10(4):200-2. Mayer EA, Tillisch K, Ellingson BM. PMID: 23507797.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    245. Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images. Neuro Oncol. 2013 May; 15(5):626-34. Naeini KM, Pope WB, Cloughesy TF, Harris RJ, Lai A, Eskin A, Chowdhury R, Phillips HS, Nghiemphu PL, Behbahanian Y, Ellingson BM. PMID: 23444259; PMCID: PMC3635524.
      View in: PubMed   Mentions: 49     Fields:    Translation:Humans
    246. Periprocedural arterial spin labeling and dynamic susceptibility contrast perfusion in detection of cerebral blood flow in patients with acute ischemic syndrome. Stroke. 2013 Mar; 44(3):664-70. Nael K, Meshksar A, Liebeskind DS, Wang DJ, Ellingson BM, Salamon N, Villablanca JP, UCLA Stroke investigators. PMID: 23391773; PMCID: PMC3584347.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    247. Pre- and post-contrast three-dimensional double inversion-recovery MRI in human glioblastoma. J Neurooncol. 2013 Apr; 112(2):257-66. Harris RJ, Cloughesy TF, Pope WB, Godinez S, Natsuaki Y, Nghiemphu PL, Meyer H, Paul D, Behbahanian Y, Lai A, Ellingson BM. PMID: 23344788; PMCID: PMC3616610.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    248. Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome. Neuro Oncol. 2013 Mar; 15(3):370-81. Lalezari S, Chou AP, Tran A, Solis OE, Khanlou N, Chen W, Li S, Carrillo JA, Chowdhury R, Selfridge J, Sanchez DE, Wilson RW, Zurayk M, Lalezari J, Lou JJ, Ormiston L, Ancheta K, Hanna R, Miller P, Piccioni D, Ellingson BM, Buchanan C, Mischel PS, Nghiemphu PL, Green R, Wang HJ, Pope WB, Liau LM, Elashoff RM, Cloughesy TF, Yong WH, Lai A. PMID: 23328811; PMCID: PMC3578486.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCells
    249. Imaging biomarkers for antiangiogenic therapy in malignant gliomas. CNS Oncol. 2013 Jan; 2(1):33-47. Leu K, Pope WB, Cloughesy TF, Lai A, Nghiemphu PL, Chen W, Liau LM, Ellingson BM. PMID: 24570837; PMCID: PMC3932329.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    250. Metabolomic analysis of cerebral spinal fluid from patients with severe brain injury. Acta Neurochir Suppl. 2013; 118:115-9. Glenn TC, Hirt D, Mendez G, McArthur DL, Sturtevant R, Wolahan S, Fazlollahi F, Ordon M, Bilgin-Freiert A, Ellingson B, Vespa P, Hovda DA, Martin NA. PMID: 23564115.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    251. Quantitative probabilistic functional diffusion mapping in newly diagnosed glioblastoma treated with radiochemotherapy. Neuro Oncol. 2013 Mar; 15(3):382-90. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Liau LM, Pope WB. PMID: 23275575; PMCID: PMC3578489.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    252. Imaging techniques in spinal cord injury. World Neurosurg. 2014 Dec; 82(6):1351-8. Ellingson BM, Salamon N, Holly LT. PMID: 23246741; PMCID: PMC3980138.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    253. Magnetic Resonance Imaging of Glioma in the Era of Antiangiogenic Therapy. PET Clin. 2013 Apr; 8(2):163-82. Khan SN, Linetsky M, Ellingson BM, Pope WB. PMID: 27157946.
      View in: PubMed   Mentions: 2     Fields:    
    254. PET Parametric Response Mapping for Clinical Monitoring and Treatment Response Evaluation in Brain Tumors. PET Clin. 2013 Apr; 8(2):201-17. Ellingson BM, Chen W, Harris RJ, Pope WB, Lai A, Nghiemphu PL, Czernin J, Phelps ME, Cloughesy TF. PMID: 27157948.
      View in: PubMed   Mentions: 1     Fields:    
    255. Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation. Neuro Oncol. 2012 Dec; 14(12):1465-72. Lazovic J, Soto H, Piccioni D, Lou JR, Li S, Mirsadraei L, Yong W, Prins R, Liau LM, Ellingson BM, Cloughesy TF, Lai A, Pope WB. PMID: 23090985; PMCID: PMC3499014.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    256. Probabilistic radiographic atlas of glioblastoma phenotypes. AJNR Am J Neuroradiol. 2013 Mar; 34(3):533-40. Ellingson BM, Lai A, Harris RJ, Selfridge JM, Yong WH, Das K, Pope WB, Nghiemphu PL, Vinters HV, Liau LM, Mischel PS, Cloughesy TF. PMID: 22997168; PMCID: PMC7964888.
      View in: PubMed   Mentions: 101     Fields:    Translation:Humans
    257. Diffusion tensor magnetic resonance tractography of the prostate: feasibility for mapping periprostatic fibers. Urology. 2012 Jul; 80(1):219-23. Finley DS, Ellingson BM, Natarajan S, Zaw TM, Raman SS, Schulam P, Reiter RE, Margolis D. PMID: 22748877.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    258. 18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumab. Neuro Oncol. 2012 Aug; 14(8):1079-89. Harris RJ, Cloughesy TF, Pope WB, Nghiemphu PL, Lai A, Zaw T, Czernin J, Phelps ME, Chen W, Ellingson BM. PMID: 22711609; PMCID: PMC3408264.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    259. Regional and voxel-wise comparisons of blood flow measurements between dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and arterial spin labeling (ASL) in brain tumors. J Neuroimaging. 2014 Jan-Feb; 24(1):23-30. White CM, Pope WB, Zaw T, Qiao J, Naeini KM, Lai A, Nghiemphu PL, Wang JJ, Cloughesy TF, Ellingson BM. PMID: 22672084.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    260. Persistent diffusion-restricted lesions in bevacizumab-treated malignant gliomas are associated with improved survival compared with matched controls. AJNR Am J Neuroradiol. 2012 Oct; 33(9):1763-70. Mong S, Ellingson BM, Nghiemphu PL, Kim HJ, Mirsadraei L, Lai A, Yong W, Zaw TM, Cloughesy TF, Pope WB. PMID: 22538078; PMCID: PMC7964759.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    261. Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study. J Neurooncol. 2012 07; 108(3):491-8. Pope WB, Qiao XJ, Kim HJ, Lai A, Nghiemphu P, Xue X, Ellingson BM, Schiff D, Aregawi D, Cha S, Puduvalli VK, Wu J, Yung WK, Young GS, Vredenburgh J, Barboriak D, Abrey LE, Mikkelsen T, Jain R, Paleologos NA, Lada P, Prados M, Goldin J, Wen PY, Cloughesy T. PMID: 22426926; PMCID: PMC3997502.
      View in: PubMed   Mentions: 101     Fields:    Translation:Humans
    262. Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma. AJNR Am J Neuroradiol. 2012 Aug; 33(7):1349-55. Carrillo JA, Lai A, Nghiemphu PL, Kim HJ, Phillips HS, Kharbanda S, Moftakhar P, Lalaezari S, Yong W, Ellingson BM, Cloughesy TF, Pope WB. PMID: 22322613; PMCID: PMC7965490.
      View in: PubMed   Mentions: 140     Fields:    Translation:HumansCells
    263. Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas. J Magn Reson Imaging. 2012 Jun; 35(6):1472-7. Ellingson BM, Zaw T, Cloughesy TF, Naeini KM, Lalezari S, Mong S, Lai A, Nghiemphu PL, Pope WB. PMID: 22281731.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    264. Functional diffusion maps (fDMs) evaluated before and after radiochemotherapy predict progression-free and overall survival in newly diagnosed glioblastoma. Neuro Oncol. 2012 Mar; 14(3):333-43. Ellingson BM, Cloughesy TF, Zaw T, Lai A, Nghiemphu PL, Harris R, Lalezari S, Wagle N, Naeini KM, Carrillo J, Liau LM, Pope WB. PMID: 22270220; PMCID: PMC3280805.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    265. 3'-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab. J Nucl Med. 2012 Jan; 53(1):29-36. Schwarzenberg J, Czernin J, Cloughesy TF, Ellingson BM, Pope WB, Geist C, Dahlbom M, Silverman DH, Satyamurthy N, Phelps ME, Chen W. PMID: 22159180; PMCID: PMC3424269.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCTClinical Trials
    266. Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. J Clin Oncol. 2011 Dec 01; 29(34):4482-90. Lai A, Kharbanda S, Pope WB, Tran A, Solis OE, Peale F, Forrest WF, Pujara K, Carrillo JA, Pandita A, Ellingson BM, Bowers CW, Soriano RH, Schmidt NO, Mohan S, Yong WH, Seshagiri S, Modrusan Z, Jiang Z, Aldape KD, Mischel PS, Liau LM, Escovedo CJ, Chen W, Nghiemphu PL, James CD, Prados MD, Westphal M, Lamszus K, Cloughesy T, Phillips HS. PMID: 22025148; PMCID: PMC3236649.
      View in: PubMed   Mentions: 241     Fields:    Translation:HumansCells
    267. Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: a radiographic study in 358 de novo human glioblastomas. Neuroimage. 2012 Jan 16; 59(2):908-16. Ellingson BM, Cloughesy TF, Pope WB, Zaw TM, Phillips H, Lalezari S, Nghiemphu PL, Ibrahim H, Naeini KM, Harris RJ, Lai A. PMID: 22001163.
      View in: PubMed   Mentions: 78     Fields:    Translation:HumansCells
    268. Novel spinal cord imaging. J Neurosurg Spine. 2011 Dec; 15(6):645-7; discussion 647. Ellingson BM, Holly LT. PMID: 21905774.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    269. Fine-tuning robot-assisted radical prostatectomy planning with MRI. Urol Oncol. 2013 Aug; 31(6):766-75. Finley DS, Margolis D, Raman SS, Ellingson BM, Natarajan S, Tan N, Huang J, Reiter RE. PMID: 21906964.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    270. Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab. Neuro Oncol. 2011 Oct; 13(10):1151-61. Ellingson BM, Cloughesy TF, Lai A, Mischel PS, Nghiemphu PL, Lalezari S, Schmainda KM, Pope WB. PMID: 21856685; PMCID: PMC3177656.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    271. Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab. J Neurooncol. 2012 Jan; 106(1):111-9. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Lalezari S, Zaw T, Motevalibashinaeini K, Mischel PS, Pope WB. PMID: 21706273.
      View in: PubMed   Mentions: 36     Fields:    Translation:Humans
    272. Nonlinear registration of diffusion-weighted images improves clinical sensitivity of functional diffusion maps in recurrent glioblastoma treated with bevacizumab. Magn Reson Med. 2012 Jan; 67(1):237-45. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Pope WB. PMID: 21702063.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    273. Advances in MRI assessment of gliomas and response to anti-VEGF therapy. Curr Neurol Neurosci Rep. 2011 Jun; 11(3):336-44. Pope WB, Young JR, Ellingson BM. PMID: 21234719; PMCID: PMC3075404.
      View in: PubMed   Mentions: 56     Fields:    Translation:Humans
    274. High order diffusion tensor imaging in human glioblastoma. Acad Radiol. 2011 Aug; 18(8):947-54. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Liau LM, Pope WB. PMID: 21536466.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    275. Cell invasion, motility, and proliferation level estimate (CIMPLE) maps derived from serial diffusion MR images in recurrent glioblastoma treated with bevacizumab. J Neurooncol. 2011 Oct; 105(1):91-101. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Pope WB. PMID: 21442275.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    276. Three-dimensional visualization of subdural electrodes for presurgical planning. Neurosurgery. 2011 Mar; 68(1 Suppl Operative):152-60; discussion 160-1. LaViolette PS, Rand SD, Raghavan M, Ellingson BM, Schmainda KM, Mueller W. PMID: 21206319; PMCID: PMC4339031.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    277. 3D visualization of subdural electrode shift as measured at craniotomy reopening. Epilepsy Res. 2011 Mar; 94(1-2):102-9. LaViolette PS, Rand SD, Ellingson BM, Raghavan M, Lew SM, Schmainda KM, Mueller W. PMID: 21334178; PMCID: PMC4329774.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    278. Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab. Neuro Oncol. 2011 Apr; 13(4):401-9. Ellingson BM, Cloughesy TF, Lai A, Nghiemphu PL, Mischel PS, Pope WB. PMID: 21324937; PMCID: PMC3064698.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    279. Spatially quantifying microscopic tumor invasion and proliferation using a voxel-wise solution to a glioma growth model and serial diffusion MRI. Magn Reson Med. 2011 Apr; 65(4):1131-43. Ellingson BM, LaViolette PS, Rand SD, Malkin MG, Connelly JM, Mueller WM, Prost RW, Schmainda KM. PMID: 21413079; PMCID: PMC3065939.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    280. Volumetric analysis of functional diffusion maps is a predictive imaging biomarker for cytotoxic and anti-angiogenic treatments in malignant gliomas. J Neurooncol. 2011 Mar; 102(1):95-103. Ellingson BM, Malkin MG, Rand SD, LaViolette PS, Connelly JM, Mueller WM, Schmainda KM. PMID: 20798977; PMCID: PMC3033973.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    281. High-resolution in vivo diffusion tensor imaging of the injured cat spinal cord using self-navigated, interleaved, variable-density spiral acquisition (SNAILS-DTI). Magn Reson Imaging. 2010 Nov; 28(9):1353-60. Ellingson BM, Sulaiman O, Kurpad SN. PMID: 20797830.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    282. Lesion growth and degeneration patterns measured using diffusion tensor 9.4-T magnetic resonance imaging in rat spinal cord injury. J Neurosurg Spine. 2010 Aug; 13(2):181-92. Ellingson BM, Schmit BD, Kurpad SN. PMID: 20672953.
      View in: PubMed   Mentions: 17     Fields:    Translation:Animals
    283. Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. J Magn Reson Imaging. 2010 Mar; 31(3):538-48. Ellingson BM, Malkin MG, Rand SD, Connelly JM, Quinsey C, LaViolette PS, Bedekar DP, Schmainda KM. PMID: 20187195; PMCID: PMC2903058.
      View in: PubMed   Mentions: 133     Fields:    Translation:Humans
    284. Utility of functional diffusion maps to monitor a patient diagnosed with gliomatosis cerebri. J Neurooncol. 2010 May; 97(3):419-23. Ellingson BM, Rand SD, Malkin MG, Schmainda KM. PMID: 19813078; PMCID: PMC2956408.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    285. Characteristics of mid- to long-latency spinal somatosensory evoked potentials following spinal trauma in the rat. J Neurotrauma. 2008 Nov; 25(11):1323-34. Ellingson BM, Kurpad SN, Schmit BD. PMID: 18976168.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    286. Ex vivo diffusion tensor imaging and quantitative tractography of the rat spinal cord during long-term recovery from moderate spinal contusion. J Magn Reson Imaging. 2008 Nov; 28(5):1068-79. Ellingson BM, Kurpad SN, Schmit BD. PMID: 18972347.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    287. Diffusion tensor MR imaging in chronic spinal cord injury. AJNR Am J Neuroradiol. 2008 Nov; 29(10):1976-82. Ellingson BM, Ulmer JL, Kurpad SN, Schmit BD. PMID: 18719029; PMCID: PMC8118946.
      View in: PubMed   Mentions: 47     Fields:    Translation:Humans
    288. Diffusion tensor MR imaging of the neurologically intact human spinal cord. AJNR Am J Neuroradiol. 2008 Aug; 29(7):1279-84. Ellingson BM, Ulmer JL, Kurpad SN, Schmit BD. PMID: 18417607; PMCID: PMC8119131.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    289. In vivo diffusion tensor imaging of the rat spinal cord at 9.4T. J Magn Reson Imaging. 2008 Mar; 27(3):634-42. Ellingson BM, Kurpad SN, Li SJ, Schmit BD. PMID: 18224673.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    290. Functional correlates of diffusion tensor imaging in spinal cord injury. Biomed Sci Instrum. 2008; 44:28-33. Ellingson BM, Kurpad SN, Schmit BD. PMID: 19141888.
      View in: PubMed   Mentions: 14     Fields:    
    291. Morphology and morphometry of human chronic spinal cord injury using diffusion tensor imaging and fuzzy logic. Ann Biomed Eng. 2008 Feb; 36(2):224-36. Ellingson BM, Ulmer JL, Schmit BD. PMID: 18066663.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    292. Gray and white matter delineation in the human spinal cord using diffusion tensor imaging and fuzzy logic. Acad Radiol. 2007 Jul; 14(7):847-58. Ellingson BM, Ulmer JL, Schmit BD. PMID: 17574135.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    293. Optimal diffusion tensor indices for imaging the human spinal cord. Biomed Sci Instrum. 2007; 43:128-33. Ellingson BM, Ulmer JL, Schmit BD. PMID: 17487069.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    294. Morphology and morphometry in chronic spinal cord injury assessed using diffusion tensor imaging and fuzzy logic. Conf Proc IEEE Eng Med Biol Soc. 2006; 2006:1885-8. Ellingson BM, Ulmer JL, Prost RW, Schmit BD. PMID: 17946920.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    295. A new technique for imaging the human spinal cord in vivo. Biomed Sci Instrum. 2006; 42:255-60. Ellingson BM, Ulmer JL, Schmit BD. PMID: 16817617.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    296. Interface parameters of impact-induced mild traumatic brain injury. Biomed Sci Instrum. 2006; 42:108-13. Fijalkowski RJ, Ellingson BM, Stemper BD, Yoganandan N, Gennarelli TA, Pintar FA. PMID: 16817594.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    297. New mechanism for inducing closed head injury in the rat. Biomed Sci Instrum. 2005; 41:86-91. Ellingson BM, Fijalkowski RJ, Pintar FA, Yoganandan N, Gennarelli TA. PMID: 15850087.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    Benjamin's Networks
    Concepts (508)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (120)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-6-g69de2244 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California